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Abstract: A synthesis of vicinal diamines via in situ aminal formation 
and carboamination of allylamines is reported herein. Employing 
highly electron poor trifluoromethyl aldimines was key to enable both 
a fast and complete aminal formation as well as the palladium-
catalyzed carboamination step. The conditions developed allow the 
introduction of a wide variety of alkynyl, vinyl, aryl and hetereoaryl 
groups with complete regioselectivity and high diastereoselectivity. 
The reaction exhibits a high functional group tolerance. Importantly, 
either nitrogen atom of the imidazolidine products can be selectively 
deprotected, while removal of the aminal tether can be achieved in a 
single step under mild conditions to reveal the free diamine. We 
expect that this work will promote the further use of mixed aminal 
tethers in organic synthesis. 
Vicinal diamines are of utmost importance in in natural 
products, agrochemicals, drugs and as chiral ligands.[1] Hence, 
tremendous efforts have been invested to develop new methods 
to access them efficiently.[2] Olefins have been widely used as 
simple and readily available substrates for the preparation of 
diamines.[3] The intermolecular diamination of alkenes through the 
formation of two new C-N bonds for example is one of the most 
direct synthetic approaches.[2h,4] However, this strategy is often 
limited in scope and leads usually to identically substituted 
nitrogen atoms, thus hampering their differentiation and further 
elaboration. Tethering both nitrogen atoms to the olefin has been 
a successful approach to meet this challenge. The diamine motif 
is then accessed either via intramolecular diamination,[5] or 
through formation of one C-N bond when starting from allylamine 
derivatives and forming a five-membered ring.[6] The latter might 
be accompanied by the simultaneous formation of another bond 
onto the olefin. In particular, ureas and sulfamates have been 
widely used in both approaches due to their robustness.[5,6] The 
use of palladium catalysis is particularly attractive, since it 
enables both the mono- and difunctionalization of olefins.[5a,c,6e-k] 
For example, Wolfe and co-workers described the use of classical 
sulfamide tethers for carboamination reactions (Scheme 1, A).[6h,i] 
However, the reaction requires strong tert-butoxide bases at 
elevated temperatures, and final cleavage of the sulfamide tether 
occurs in presence of HBr at 130 °C for a prolonged period of 
time. Such harsh conditions are highly detrimental for the 
tolerance to functional groups and the scope of the reaction. 
In this context, we were attracted by the use of aminals as 
Csp3 tethers,[7] which have received much less attention than the 
classical urea and sulfamide tethers. They offer the precious 
advantage of being potentially more easily installed and removed, 
and could still engage efficiently in olefin functionalization 
processes. Furthermore, the obtained imidazolidine products 
provide a direct access to other highly important nitrogen-
containing heterocycles such as imidazolines, imidazoles and N-
heterocyclic carbenes.[8] Among the scarce reports employing 
aminals as tethers, only two groups described the 
functionalization of non-activated olefins (Scheme 1, B and C).[9] 
The seminal contribution of Hiemstra and coworkers describes 
the use of aminal tethers for Aza-Wacker cyclizations starting 
from allylic amines. However, tether installation and removal 
proved to be tedious, requiring five separate steps (Scheme 1, 
B).[9a] More recently, Beauchemin and coworkers reported a 
Cope-type hydroamination of simple allylamines in one step 
(Scheme 1, B).[9b-f] While elegant, both works remain limited to a 
single C-N bond formation.  
 
 
Scheme 1. Synthesis of diamines using a tether approach. 
 
Recently, our group has demonstrated that vicinal amino 
alcohols could be synthesized from allyl amines using an acetal 
tether and a palladium catalyst to form simultaneously one new 
C-O and C-C bond.[10a] We envisioned that an allylic amine and 
an imine could in situ form an aminal, which would undergo a Pd-
catalyzed carboamination reaction to generate an imidazolidine 
via formation of both a C-N and a C-C bond (Scheme 1, D).[11] All 
the reported mixed aminals employed for olefin functionalization 
bear electron-withdrawing groups on both nitrogen atoms, which 
greatly stabilize them. However, the poor nucleophilicity of the 
amine precursor prevents their fast synthesis.[7] We thought to 
use nucleophilic allylamines to solve this issue. Three challenging 
conditions must be met to ensure the success of the envisioned 
transformation:  
(i)  formation of the aminal must be complete, fast and 
selective to avoid side reactions or catalyst deactivation,  
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(ii)  the mixed aminal formed needs to be both stable and 
suitable for the envisioned Pd-catalyzed carboamination,  
(iii)  the imidazolidine obtained must be stable under the 
reaction conditions to avoid catalyst poisoning, but still be 
amenable to a straightforward deprotection to free the diamine.  
The efficient implementation of this approach is reported 
herein, employing electron-rich allylamines, carbamate-protected 
trifluoroaldimines and a bromide, in presence of a commercially 
available palladium source and phosphine ligands. The 
developed conditions allowed for a broad scope in both 
allylamines and alkynyl, aryl or vinyl bromides, as well as for high 
stereo-, regio- and diastereoselectivity.  
We started our studies with benzylallyl amine (1) and silyl 
acetylene 3 as efficient electrophilic partner in Pd0/PdII catalyzed 
olefin functionalization (Table 1).[10,12] We identified aldimine 
precursor 2a as efficient tethering reagent in combination with 
Pd2dba3 as palladium source, P(2-furyl)3 as ligand, and cesium 
carbonate as base. Under these conditions, imidazolidine 4 was 
isolated in excellent yield and diastereoselectivity (95%, dr > 
20:1) (entry 1). Importantly, 2a is easily available on multigram 
scale,[13] bench stable for months, and only a slight excess is 
required to achieve complete conversion to 4. As anticipated, the 
choice of the tether played a crucial role on the reaction outcome. 
Electron neutral aldimine 2b  
Table 1. Optimization of the tethered aminoalkynylation.[a] 
 
Entry Changes from standard conditions Yield (%)[b] 
1 none 99 (95)[c] 
2 2b instead of 2a <3 
3 2c instead of 2a 15 
4 2d instead of 2a 36 
5 2e instead of 2a 5 
6 2f instead of 2a 35 
7 2g instead of 2a 45 
8 2h instead of 2a 5 
9 2i instead of 2a 7 
10 PPh3 (12 mol%) instead of P(2-furyl)3 39 
11 PhDavePhos (11 mol%) instead of P(2-furyl)3 81 
12 DavePhos (11 mol%) instead of P(2-furyl)3 11 
13 BINAP (6 mol%) instead of P(2-furyl)3 3 
14 DPEPhos (6 mol%) instead of P(2-furyl)3 90 
15 XANTPhos (6 mol%) instead of P(2-furyl)3 58 
16 CsHCO3 instead of Cs2CO3 44 
17 K2CO3 instead of Cs2CO3 89 
18 Benzyl allylcarbamate instead of 1 8 
19 without Pd2dba3 or P(2-furyl)3 or base <3 
[a]Reactions conditions: 0.10 mmol 1, 0.11 mmol 2a, 0.13 mmol 3, 0.33 M in 
PhMe, 20 h. [b]NMR yield using 3,4,5-trichloropyridine as internal standard. 
[c]Isolated yield on 0.30 mmol scale. 
 
was ineffective (entry 2), while more activated N-Boc aryl imines 
still suffered from poor reactivity (entries 3-4). Various N-
protected trifluoromethyl aldimines did provide some 
improvement, but furnished inferior results than 2a (entries 5-9). 
Changing the ligand had also a profound effect. Whereas using 
simple triphenylphosphine decreased the yield (entry 10), the 
bulky PhDavePhos afforded 4 in high yield (entry 11). The 
electron-rich DavePhos was not efficient (entry 12). Regarding 
bidentate phosphines, BINAP was not competent, DPEPhos 
yielded 90% of 4, and the closely related XANTPhos only 58% 
(entries 13-15). Switching to cesium hydrogen carbonate as base 
still afforded significant amount of 4, while potassium carbonate 
provided 89% of the desired imidazolidine (entries 16-17). The 
use of such mild bases is very rare for Pd0/PdII-catalyzed 
carboamination reactions, which often require stronger alkoxides. 
Deactivating the allylamine with a carbamate protecting group led 
to very low conversion (entry 18). Finally, without palladium or 
ligand or base, 4 was not observed (entry 19). 
 
The scope of the reaction was then examined (Scheme 2). 
We performed an assessment of functional group tolerance and 
electronic effects by varying the substitution on the nitrogen 
atoms (Scheme 2, A). The use of a methyl carbamate protected 
tether also provided product 5 in excellent yield. Modifying the 
benzyl group with electron donating or withdrawing groups had 
only minor influence (products 5-10). Both the useful aryl bromide 
(product 8) and chloride (product 9) were preserved under these 
conditions. When performed on gram-scale, compound 10 was 
obtained in quantitative yield. A simple allyl group was also 
tolerated, with no Heck side reaction observed (product 11). 
Imidazolidines bearing a furan heterocycle or a ferrocene group 
were obtained in 92 and 89% yield respectively (products 12 and 
13). The use of primary allylamines was also possible (product 
14). Finally, replacing an aliphatic amine by an aniline still 
furnished the desired imidazolidine 15 in high yield.  
Geminal substitution of the olefin was possible when using 
PhDavePhos as ligand (Scheme 2, B????-Tertiary amine 16 and 
17 were formed in good to high yields and with high 
diastereoselectivity (dr > 20:1).  
???????????????????????-substituted allylamines (Scheme 2, C).[14] 
This class of substrates required the use of cesium triflate as 
additive to ensure high conversions.[15] Substitution by a methyl 
group furnished the desired imidazolidines 18 in high yield, albeit 
in low diastereoselectivity. A bis-allylic amine delivered 19 in good 
yield and diastereoselectivity. Bicyclic and tricyclic imidazolidines 
20, 21 and 22 were formed in high diastereoselectivity. These 
results highlight the fast access to complex structures with control 
on up to four stereocenters in a single step. 
The scope of organohalides was then examined. Alkynes 
derived from secondary and tertiary propargylic alcohols 
underwent the desired transformation in good to excellent yields 
(Scheme 2, D, products 23-26). Notably, both aliphatic and 
aromatic substituents were tolerated at the propargylic position.  
We then turned our attention to aryl bromides (Schemes 2, E and 
F). This class of electrophiles could be used as long as they were 
slightly activated with an electron-withdrawing group. While 
DPEPhos was a competent ligand in certain cases, the 
combination of P(2-furyl)3 with cesium  
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Scheme 2. Scope of the tandem aminal formation carboamination reaction[a] 
 
[a]dr > 20:1 unless otherwise noted; dr in parenthesis represents the diastereoisomeric ratio in the crude reaction mixture if different from the one of the isolated 
compound. [b]P(2-Furyl)3 (12 mol%) was used as ligand. [c]PhDavePhos (15-20 mol%) was used as ligand. [d]P(2-Furyl)3 (24 mol%) was used as ligand and cesium 
triflate as additive (1.2 equiv). [e]DPEPhos (12 mol%) was used as ligand. 
triflate as additive was more general
 
and reliable. Ortho and para 
substitution were well tolerated (products 27-32). 1,2-Dibromo 
aryls underwent the reaction smoothly to afford brominated 
products 29 and 30, which open up possibilities for further 
derivatizations. Substitution at the meta positions cleanly 
delivered the desired products 33 and 34 bearing an ?-
secondary and an ?-tertiary amine respectively. Due to the 
importance of aromatic heterocycles in the agrochemical and 
pharmaceutical industries, several heteroaryl bromides were 
then submitted to the reaction conditions (Scheme 2, F). 
Gratifyingly, both fluoropyridine and chloropyrimidine were 
introduced in good to excellent yields (products 35 and 36). 
Imidazolidines 37 and 38 bearing either a furan or a thiophene 
ring could be obtained in 81 and 82% yield respectively. Finally, 
aminoalkenylation was also possible (Scheme 2, G). 
Trifluoromethyl-substituted olefin 39 could be isolated in 87% 
yield.  
To highlight the synthetic potential of the obtained building 
blocks, we synthesized either of the free amines selectively 
(Scheme 3). Starting from 10, oxidative cleavage of the para-
methoxybenzyl (PMB) protecting group lead to free amine 14 in 
high yield, while heating under microwave irradiation cleanly 
removed the boc group to access 40 in nearly quantitative yield. 
TIPS removal with TBAF yielded terminal alkyne 41 in 98% yield. 
Finally, cleavage of the aminal was performed. Using HCl in 
methanol delivered diamine salt 42 in 89% yield. Treatment of 
imidazolidines 20 and 34 with trifluoroacetic acid followed by 
addition of methanol allowed full removal of the tether in 
excellent yields, without any further purification. The mild acidic 
conditions used are routinely applied in peptide chemistry. 
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Scheme 3. Orthogonal deprotections. Reaction conditions: a) DDQ, MeCN, 
H2O, rt; b) microwave irradiation (160 °C), H2O/Ethanol; c) TBAF, THF, 0 °C to 
rt; d) HCl, MeOH, -40 °C to rt; e) TFA, CH2Cl2 then MeOH, 0 °C to rt. 
 
In conclusion, we have developed the first palladium-
catalyzed carboamination of allylamines employing an in situ 
installed Csp3 aminal tether for the synthesis of 1,2-diamines. 
The use of carbamate-protected trifluoroaldimines allowed 
excellent regio- and diastereoselectivities under mild reactions 
conditions, a high functional-group tolerance and a broad scope. 
The versatility of our method was demonstrated by the 
introduction of alkynyl, aryl, heteroaryl and vinyl groups onto the 
allylamines. Both free amines could be obtained orthogonally, 
while complete tether cleavage to give diamines was performed 
under mild conditions. Based on our results, we expect that the 
use of aminal tethers will find much broader application in the 
future. 
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1. General Methods 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, unless 
stated otherwise. For quantitative flash chromatography technical grade solvents were used. For 
flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were used. THF, 
Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated alumina under 
nitrogen atmosphere (H2O content < 10 ppm, Karl-Fischer titration).  In some cases solvents 
were degassed using freeze-thaw cycle. All chemicals were purchased from Acros, Aldrich, 
Fluka, VWR, Fluorochem, Aplichem or Merck and used without further purification, unless 
stated otherwise. Chromatographic purification was performed as flash chromatography using 
Macherey-Nagel silica 40-63, 60 Å, using the solvents indicated as eluent with 0.1-0.5 bar 
pressure. TLC was performed on Merck silica gel 60 F254 TLC aluminium plates and visualized 
with UV light and potassium permanganate stain. Melting points were measured on a calibrated 
Büchi B-540 melting point apparatus using open glass capillaries. 1H-NMR spectra were 
recorded on a Bruker DPX-400 400 MHz spectrometer in chloroform-d unless otherwise stated. 
All signals are reported in ppm with the internal chloroform signal at 7.26 ppm as standard unless 
otherwise stated. The data is being reported as (s = singlet, d = doublet, t = triplet, q = 
quadruplet, qi = quintet, m = multiplet or unresolved, br = broad signal, app = apparent, 
coupling constant(s) in Hz, integration, interpretation).13C-NMR spectra were recorded with 1H-
decoupling on a Bruker DPX-400 100 MHz spectrometer in chloroform-d unless otherwise 
stated.
 
All signals are reported in ppm with the internal chloroform signal at 77.16 ppm as 
standard unless otherwise stated. Infrared spectra were recorded on a JASCO FT-IR B4100 
spectrophotometer with an ATR PRO410-S and a ZnSe prisma and are reported as cm-1 (w = 
weak, m = medium, s = strong, br = broad). Gas chromatographic and low resolution mass 
spectrometric measurements were performed on a Perkin-Elmer Clarus 600 gas chromatographer 
and mass spectrometer using a Perkin-Elmer Elite fused silica column (length: 30 m, diameter: 
0.32 mm) and Helium as carrier gas. High resolution mass spectrometric measurements were 
performed by the mass spectrometry service of ISIC at the EPFL on a MICROMASS (ESI) Q-
TOF Ultima API. Cesium carbonate was purchased from Aldrich and used without further 
purification. The bulk of this material was stored under nitrogen in a Vacuum Atmospheres 
Glovebox. Small portions (3-5 g) were removed from the glovebox in glass vials and weighed in 
the air. DPEPhos was purchased from Acros, PhDavePhos from ABCR and tri(2-furyl)phosphine 
was purchased from Aldrich. N-benzylprop-2-en-1-amine (1), N-(4-bromobenzyl)prop-2-en-1-
amine, N-(4-methoxybenzyl)prop-2-en-1-amine, N-(2-chlorobenzyl)prop-2-en-1-amine, 
diallylamine, N-(furan-2-ylmethyl)prop-2-en-1-amine, allylamine (49), N-allyl-4-
methoxyaniline, N-benzyl-2-methylprop-2-en-1-amine and N,1-diphenylmethanimine (2b) are 
commercially available from Fluorochem, Aldrich and Acros. Aldimine 2c,1 2d,2 2e,3 2g4 were 
synthesized according to reported procedures. Aryl and vinyl bromides were bought from 
Aldrich, Acros, ABCR, TCI and Fluorochem, and used as received. Diastereomeric mixtures 
have been assigned by 1D and 2D NMR experiments including COSY/NOESY/HSQC/HMBC. 
 
  
                                                 
1
 Wenzel, A. G.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 12964. 
2
 Nugent, B. M.; Yoder, R. A.; Johnston, J. N J. Am. Chem. Soc. 2004, 126, 3418. 
3
 Mimura, H.; Kawada, K.; Yamashita, T.; Sakamoto, T.; Kikugawa, Y J. Fluor. Chem. 2010, 131, 477. 
4
 Kumadaki, I.; Jonoshita, S.; Harada, A.; Omote, M.; Ando, A. J. Fluor. Chem. 1999, 97, 61. 
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2. Optimization. 
General method for the optimization: 
A sealed oven-dry microwave vial under nitrogen was charged with dry degassed toluene (0.3 
mL), the tether, the allylamine (0.100 mmol, 1.0 eq), the base and 
(bromoethynyl)triisopropylsilane (34 mg, 0.13 mmol, 1.3 eq). The resulting solution was stirred 
30-60 min at 50 °C. Then a premixed solution of the palladium source and the ligand in dry 
degassed toluene (0.20 mL) was added. The resulting mixture was stirred at 60-70 °C for 15-20 
h. The reaction mixture was cooled to 23 °C, filtered and concentrated under reduced pressure 
and analyzed by NMR spectroscopy. The yield was determined using either 3,4,5-
trichloropyridine for 1H NMR (integration of propargylic protons) or benzotrifluoride for the 19F 
NMR as internal standards. 
 
Table 1. Optimization for the mono-substituted allyl amines. 
 
Entry Changes from standard conditions Yield (%)b 
1 none 99 (95)c 
2 Na2CO3 instead of Cs2CO3 <5 
3 Rb2CO3 instead of Cs2CO3 80 
4 KOt-Bu instead of Cs2CO3 78 
5 MTBD instead of Cs2CO3 38 
6 Phosphazene P2Et instead of Cs2CO3 55 
7 1.8 equiv of 2a instead of 1.1 94 
8 2.5 equiv of 2a instead of 1.1 76 
9 0.4 M instead of 0.33 M 92 
10 0.2 M instead of 0.33 M 80 
11 1 mol% of Pd2dba3 instead of 2 mol% 81 
12 [(cinnamyl)PdCp] instead of Pd2dba3  88 
aReaction conditions: 0.10 mmol 1, 0.11 mmol 2a, 0.13 mmol 3, 0.33 M in PhMe, 20 h. bNMR yield 
using 3,4,5-trichloropyridine as internal standard. cIsolated yield on 0.30 mmol scale.  
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Table 2. Optimization for the gem-disubstituted allyl amines. 
 
Entry Changes from standard conditions Yield (%)b 
1 none 93 (85)c 
2 DPEPhos (9 mol%)  instead of PhDavePhos 40 
3 XantPhos (9 mol%)  instead of PhDavePhos 16 
4 (4-CF3-C6H4)DavePhos (15 mol%) instead of  13 
5 P(2-furyl)3 (18 mol%)  instead of PhDavePhos 8 
6 0.28 M instead of 0.33 M 85 
aReaction conditions: 0.10 mmol 45, 0.11 mmol 2a, 0.13 mmol 3, 0.33 M in PhMe, 20 h. bNMR yield 
using 3,4,5-trichloropyridine as internal standard. cIsolated yield on 0.30 mmol scale.  
 
Table 3. Optimization for the ?-branched substituted allyl amines. 
 
Entry Changes from standard conditions Yield (%)b 
1 none 80 
2 0.05 M instead of 0.33 M 32 
3 0.1 M instead of 0.33 M 45 
4 0.2 M instead of 0.33 M 75 
5 PPh3 instead of P(2-furyl)3 7 
6 P(4-CF3-C6H4)3 (24 mol%) instead of P(2-furyl)3 31 
7 P(2-thienyl)3 (24 mol%) instead of P(2-furyl)3 18 
8 CyPPh2 (24 mol%) instead of P(2-furyl)3 <5 
9 dppf (12 mol%) instead of P(2-furyl)3 <5 
10 DPEPhos (12 mol%)  instead of P(2-furyl)3 35 
11 XantPhos (12 mol%)  instead of P(2-furyl)3 6 
12 At 65 °C instead of 75 °C 62 
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13 At 85 °C instead of 75 °C 70 
14 [(cinnamyl)PdCp] instead of Pd2dba3 63 
15 Pd(dba)2 instead of Pd2dba3 64 
16 Pd(OAc)2 instead of Pd2dba3 42 
17 PhCF3 instead of PhMe 44 
18 Dioxane instead of PhMe 53 
19 t-amyl alcohol:PhMe 5:1 instead of PhMe 70 
20 LiOt-Bu instead of Cs2CO3 32 
21 NaOt-Bu instead of Cs2CO3 38 
22 KOt-Bu instead of Cs2CO3 63 
23 With LiOTf (1.2 equiv) as additive 88 
24 With NaOTf (1.2 equiv) as additive 85 
25 With KOTf (1.2 equiv) as additive 65 
26 With CsOTf (1.2 equiv) as additive 97 
aReaction conditions: 0.10 mmol 46, 0.11 mmol 2a, 0.13 mmol 3, 0.33 M in PhMe, 20 h. bNMR yield 
using trifluorotoluene as internal standard.  
 
Table 4. Optimization for the aryl bromides. 
 
Entry Changes from standard conditions Yield (%)b 
1 none 90 (82)c 
2 without CsOTf 41 
3 DPEPhos (12 mol%)  instead of P(2-furyl)3 83 
4 DPEPhos (12 mol%)  instead of P(2-furyl)3 without CsOTf 78 
5 XANTPhos (12 mol%)  instead of P(2-furyl)3 without CsOTf 65 
6 PhDavePhos (20 mol%)  instead of P(2-furyl)3 without CsOTf 15 
7 At 50 °C instead of 70 °C. 30 
aReaction conditions: 0.10 mmol 1, 0.11 mmol 2a, 0.15 mmol 47, CsOTf (1.2 equiv), 0.30 M in PhMe, 
20 h. bNMR yield using 3,4,5-trichloropyridine as internal standard.  
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3. Proposed mechanism. 
 
Based on observations and detailed mechanistic studies of the ?????????????,5 and observation in 
our group,6 we proposed the following mechanism for the aminoalkynylation reaction (Scheme 
S1). First oxidative addition of alkynyl bromide 3 onto the Pd0 catalyst I would form PdII-alkynyl 
intermediate II. Ligand exchange of the bromine with the in situ generated mixed aminal V give 
complex VII. Then, intramolecular aminopalladation of the olefins would likely occur in a syn 
manner to deliver the alkyl-Pd complex VII. Finally, reductive elimination would yield the 
imidazolidine IX and regenerate the Pd0 catalyst I. The diastereoselectivity observed would arise 
from a highly organized chair-like transition-state in which the Pd-N bond is eclipsed with the 
olefin. The CF3 would adopt a pseudo-axial conformation to minimize A1,3-strain with the Boc 
group, while the R1 group would adopt a pseudo-equatorial conformation to minimize 1,3-diaxial 
interaction. 
Regarding the formation of the mixed aminal V, it would start with the formation of the Boc-
protected trifluoromethyl aldimine III under basic conditions. Subsequent nucleophilic addition 
of allylamine IV onto III would yield V. The stability of V most likely arises from the 
trifluoromethyl group that disfavor the formation of highly destabilized iminium VI.  
 
 
                                                 
5
 (a) J. E. Ney, J. P. Wolfe, J. Am. Chem. Soc., 2005, 127, 8644. (b) J. D. Neukom, N. S. Perch, J. P. Wolfe, J. Am. 
Chem. Soc., 2010, 132, 6276. (c) J. D. Neukom, N. S. Perch, J. P. Wolfe, Organometallics, 2011, 30, 1269. 
6
 S. Nicolai, R. Sedigh-Zadeh, J. Waser, J. Org. Chem 2013, 78, 3783. 
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Scheme S1. Proposed mechanism for the aminoalkynylation reaction. 
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4. Preparation of allylamines. 
N-(4-(Trifluoromethyl)benzyl)prop-2-en-1-amine (50) 
 
4-(Trifluoromethyl)benzaldehyde (48) (1.37 mL, 10.0 mmol, 1.0 eq) and prop-2-en-1-amine (49) 
(0.571 g, 10.0 mmol, 1.0 eq) were mixed in 1,2-dichloroethane (35 mL) and then treated with 
sodium triacetoxyborohydride (3.0 g, 14 mmol, , 1.4 eq). The mixture was stirred at rt under a N2 
atmosphere for 2.5 h. The reaction mixture was quenched by adding aqueous saturated NaHCO3 
(15 mL), and the product was extracted with EtOAc (3x30 mL). The EtOAc extract was dried 
(MgSO4), and the solvent was evaporated under reduced pressure. The crude product was purified 
by column chromatography (SiO2, 10:1:0.1 Pentane:EtOAc:Et3N) to afford the title compound 50 
as a pale yellow oil (1.83 g, 8.50 mmol, 85% yield). 
 
Rf 0.20 (Pentane:EtOAc 4:1).  
1H NMR (400 MHz, Chloroform-d) ? 7.58 (d, J = 8.0 Hz, 2H, ArH), 7.45 (d, J = 8.0 Hz, 2H, 
ArH), 5.92 (ddt, J = 17.2, 10.3, 6.0 Hz, 1H, CHCH2), 5.21 (m, 1H, CHCH2), 5.14 (m, 1H, 
CHCH2), 3.86 (s, 2H, ArCH2), 3.28 (m, 2H, NCH2), 1.65 (bs, 1H, NH). 
13C NMR (101 MHz, Chloroform-d) ???????????6.5, 129.4 (q, J = 32.2 Hz), 128.5, 125.5 (m), 
124.5 (q, J = 272.2 Hz), 116.5, 52.7, 51.8. 
IR ?max 3394 (w), 2831 (w), 2830 (w), 1646 (w), 1620 (w), 1458 (w), 1420 (w), 1329 (s), 1167 
(m), 1127 (s), 1069 (w), 1021 (w), 925 (w), 844 (w), 823 (w), 796 (w), 784 (w), 763 (w), 728 
(w). 
HRMS (ESI) calcd. for C11H13F3N+ [M+H]+ 216.0995; found 216.0994. 
 
 
4-((Allylamino)methyl)benzaldehyde (52) 
 
To a solution of commercially available 4-((allylamino)methyl)benzonitrile (51) (0.861 g, 5.00 
mmol, 1.0 eq) in anhydrous toluene (12.5 mL) was added DIBAL-H (1 M in hexane, 6.50 mL, 
6.50 mmol, 1.3 eq), keeping the internal temperature between -10 and -5 °C. After stirring at 0 °C 
for 2 h, ice cold HCl (10% aq. sol., 50 mL) was added carefully. The layers were separated and 
the aqueous phase washed with CH2Cl2 (3x15 mL). The resulting aqueous layer was basified (pH 
14) with KOH and extracted with CH2Cl2 (3x50 mL). The combined organic layers were washed 
with saturated aqueous NaCl and dried (MgSO4). The solvent was evaporated to give the crude 
product that was purified by passing through a short pad of silica, eluting with EtOAc to afford 
the pure title compound 52 as a pale yellow oil (0.797 g, 4.55 mmol, 91% yield). 
N. B.: this compound readily polymerized, preventing us from obtaining a clean 13C NMR 
spectrum. 
 
1H NMR (400 MHz, Chloroform-d) ? 10.00 (s, 1H, CHO), 7.89 ? 7.78 (m, 2H, ArH), 7.57 ? 7.45 
(m, 2H, ArH), 5.93 (ddt, J = 17.1, 10.2, 6.0 Hz, 1H, CHCH2), 5.25 ? 5.17 (m, 1H, CHCH2), 5.16 
? 5.10 (m, 1H, CHCH2), 3.89 (s, 2H, ArCH2), 3.29 (m, 2H, NCH2), 1.52 (bs, 1H, NH). 
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IR ?max 3664 (w), 3074 (w), 2995 (w), 2916 (w), 2827 (m), 2735 (w), 1698 (s), 1643 (w), 1607 
(m), 1578 (w), 1449 (w), 1420 (w), 1389 (w), 1363 (w), 1341 (w), 1304 (w), 1254 (w), 1210 (m), 
1166 (m), 1108 (w), 1072 (w), 997 (m), 922 (m), 848 (m), 823 (m), 783 (m). 
HRMS (ESI) calcd. for C11H14NO+ [M+H]+ 176.1070; found 176.1068. 
 
Ferrocenylmethyl allylamine (54) 
 
Following a slightly modified procedure,7 to a solution of ferrocenecarboxaldehyde (53) (700 mg, 
3.27 mmol) in MeOH (14 mL) was added allylamine (49) (0.270 ml, 3.60 mmol, 1.1 equiv) and 
the mixture was stirred at room temperature for 30 min. The mixture was cooled to 0 °C and solid 
NaBH4 (0.148 g, 3.92 mmol, 1.2 equiv) was added in two portions. Then the solution was 
allowed to warm to room temperature and was stirred for another 30 min. The solvent was 
removed, diluted with EtOAc and quenched with saturated aqueous NaHCO3. The organic layer 
was separated, washed with brine, dried over MgSO4, and concentrated under reduced pressure. 
Ferrocenylmethyl allylamine (54) was obtained as dark oil (750 mg, 3.22 mmol, 90 %) without 
further purification. 
 
1H NMR (400 MHz, Chloroform-d) ? 5.92 (ddt, J = 16.5, 10.3, 6.0 Hz, 1H, CHCH2), 5.20 (dd, J 
= 17.2, 1.6 Hz, 1H, CHCH2), 5.12 (dd, J = 10.3, 1.6 Hz, 1H, CHCH2), 4.22 ? 4.04 (m, 9H, 
FerroceneH), 3.53 (s, 2H, FerroceneCH2), 3.29 (d, J = 6.0 Hz, 2H, NCH2), 1.67 (s, 1H, NH). 
13C NMR (101 MHz, Chloroform-d) ? 137.0, 116.0, 87.0, 68.5, 67.8, 52.1, 48.4. 
Spectra data was consistent with the values reported in literature.7 
 
 
N-benzyl-2-((benzyloxy)methyl)prop-2-en-1-amine (56) 
 
Multistep procedure: 
1) Benzyl alcohol (0.572 mL, 5.50 mmol, 1.1 equiv) was added to a mixture of NaH (120 mg, 
5.00 mmol, 1 equiv) in THF (5.0 mL) at rt. The reaction mixture was stirred for 1 h at this 
temperature and then slowly transferred to a solution of 3-chloro-2-(chloromethyl)prop-1-ene 
(55) (656 mg, 5.25 mmol, 1.05 equiv) in THF (Ratio: 1.000, Volume: 5.0 mL) at 0 °C. The 
reaction mixture was stirred for 12 h at rt and then quenched with 1N HCl. The crude residue was 
purified by column chromatography on Biotage (SNAP cartridge KP-SIL 50 g, 99:1 to 92:8 
Pentane:Et2O) to afford a yellow oil (0.530 g, 2.69 mmol, 54% yield) which was directly used in 
the next step. 
 
2) (((2-(chloromethyl)allyl)oxy)methyl)benzene (0.415 g, 2.11 mmol) was slowly added to a 
mixture of K2CO3 (0.350 g, 2.53 mmol) and phenylmethanamine (1.20 mL, 11.2 mmol) at 0 °C. 
The reaction mixture was stirred for 3 h, diluted with DCM (30 mL), filtered and concentrated 
                                                 
7
 Gobe, V.; Retailleau, P.; Guinchard, X. Org. Lett. 2014, 16, 5438. 
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under reduced pressure. The residue was purified by column chromatography (SiO2, 
Pentane:EtOAc:Et3N 100:10:1) to afford the title compound 56 (320 mg, 1.20 mmol, 57%) as a 
pale yellow oil. 
 
Rf 0.25 (Pentane:EtOAc 4:1).  
1H NMR (400 MHz, Chloroform-d) ? 7.37 ? 7.29 (m, 8H, ArH), 7.29 ? 7.22 (m, 2H, ArH), 5.20 
? 5.17 (m, 1H, C=CH2), 5.17 ? 5.15 (m, 1H, C=CH2), 4.51 (s, 2H, PhCH2O), 4.07 (s, 2H, O 
CH2CCH2), 3.78 (s, 2H PhCH2N), 3.36 ? 3.30 (m, 2H, CH2N), 1.58 ? 1.38 (m, 1H, NH). 
13C NMR (101 MHz, Chloroform-d) ? 144.4, 140.5, 138.4, 128.5, 128.5, 128.3, 127.8, 127.7, 
127.0, 113.4, 72.3, 72.2, 53.3, 51.7. 
IR ?max 3523 (w), 3450 (w), 3347 (w), 3308 (w), 3068 (m), 3029 (m), 2842 (m), 1956 (w), 1877 
(w), 1818 (w), 1683 (w), 1658 (w), 1603 (w), 1493 (w), 1451 (m), 1365 (w), 1308 (w), 1080 (s), 
1026 (m), 974 (w), 912 (m), 817 (w). 
HRMS (ESI) calcd. for C18H22NO+ [M+H]+ 268.1696; found 268.1691.  
 
N-Benzylbut-3-en-2-amine (46) 
 
Following a reported procedure, 8 
1) MeSO2Cl (2.86 g, 25.0 mmol, 1.25 eq) was added dropwise at 0 °C to a CH2Cl2 (60 mL) 
solution of but-3-en-2-ol (57) (1.44 g, 20.0 mmol, 1.0 eq) and Et3N (3.04 g, 30.0 mmol, 1.5 eq). 
The mixture was stirred at the same temperature for 2 h, resulting in a large amount of white 
precipitate. Saturated Na2CO3 (30 mL) was then added to quench the reaction. After the 
separation of the organic layer, extraction of the aqueous layer with CH2Cl2 (20 mL x 2) and 
washing with brine, the combined organic layer was dried with MgSO4. The solvent was 
removed under reduced pressure, and the residue was dried under vacuum to afford but-3- en-2-yl 
methanesulfonate (3.15 g, 21.0 mmol, <= 100%), which was used directly in next step.  
2) But-3-en-2-yl methanesulfonate (2.13 g, 14.0 mmol, 1.0 eq) was added dropwise to a rapidly 
stirring neat benzyl amine solution (4.50 g, 42.0 mmol, 3.0 eq) at room temperature. After stirring 
overnight, NaOH (10%, 10 mL) was added. After extraction with CH2Cl2 (20 mL), separation of 
organic layer, drying with Na2SO4, and removal of the solvent under reduced pressure, the 
residue was purified by column chromatography (EtOAc:Hexanes 3:1) to afford the title 
compound 46 as a colorless oil (2.48 g, 15.4 mmol, 77% yield for 2 steps).  
 
1H NMR (400 MHz, Chloroform-d????7.30-7.22 (m, 5H, ArH), 5.72 (ddd, J = 17.6, 10.1, 7.6 Hz 
1H, CHCH2), 5.14 (m, 1H, CHCH2), 5.09 (m, 1H, CHCH2), 3.80 (d, J = 13.1 Hz 1H, PhCH2), 
3.67 (d, J = 13.1 Hz 1H, PhCH2), 3.20 (m, 1H, NCH), 1.26 (br, NH, 1H, NH) 1.16 (d, J = 6.5 Hz, 
3H, Me). 
13C NMR (100 MHz, Chloroform-d) ? 142.7, 140.8, 128.5, 128.3, 126.9, 114.8, 56.2, 51.5, 21.9. 
1H NMR data is consistent with the values reported in literature.9 
 
 
                                                 
8
 Zhao, S.-B.; Bilodeau, E.; Lemieux, V.; Beauchemin, A. M. Org. Lett. 2012, 14, 5082. 
9
 Dubovyk, I.; Watson, I. D. G.; Yudin, A. K. J. Am. Chem. Soc. 2007, 129, 14172. 
S11 
 
N-benzylpenta-1,4-dien-3-amine (59) 
 
 
Multistep procedure: 
1) Following a slightly modified procedure,10 to a solution of acrylaldehyde (58) (1.74 mL, 25.8 
mmol, 1.25 equiv) and 2-methylpropane-2-sulfinamide (2.50 g, 20.6 mmol) in DCM (15 mL) 
was added tetraethoxytitanium (12.1 mL, 58.0 mmol, 2.8 equiv). The mixture was stirred at room 
temperature for 1.5 h, then poured into a mixture of ice/water and stirred for 30 min. The white 
suspension was filtered through Celite and the cake rinsed with DCM. The organic layer was 
separated and the aqueous layer extracted with DCM (3x20 mL). The combined organic layers 
were dried (MgSO4) and concentrated in vacuo. Purification by column chromatography (SiO2, 
DCM) afforded the desired imine (2.53 g, 15.9 mmol, 77%) as a light yellow oil.  
 
2) Vinylmagnesium bromide (1.0 M solution in THF, 10.3 mL, 10.3 mmol, 2 equiv) was slowly 
added to a solution of the imine (820 mg, 5.15 mmol) in DCM (26 mL) at -40 °C. The reaction 
mixture was slowly warmed up to rt overnight. The reaction was quenched with a 1:1:1 mixture 
of water, brine and NH4Cl (30 mL). The layers were separated and the aqueous layer extracted 
with DCM (3x20 mL). The organic layers were combined, dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude oil was purified by column chromatography 
(SiO2, Pentane:EtOAc 5:1 to 1:1) to afford the desired sulfinamide (460 mg, 2.46 mmol, 48%) 
which was directly engaged in the next step. 
 
3) A flame-dried flask was charged with the sulfinamide (300 mg, 1.60 mmol) and DMF (5.3 
mL). The resulting solution was cooled to -40 °C. LiHMDS (1 M in THF, 1.60 mL, 1.60 mmol, 
1.05 equiv) was added dropwise over 5 minutes. The solution was allowed to stir for 1 h at this 
temperature. Then benzyl bromide (0.38 mL, 3.2 mmol, 2 equiv) was added dropwise over 10 
minutes. At this time, the resulting solution was warmed up to room temperature and was stirred 
for 2 h. The reaction was slowly quenched at 0 °C by the addition of a saturated aqueous solution 
of ammonium chloride, the layers of the resulting biphasic mixture were separated and the 
aqueous layer was extracted with EtOAc (3x). The combined organic layers were washed with 
water (4x) and brine (2x), dried over MgSO4, filtered, and concentrated under reduced pressure. 
The crude residue was purified by column chromatography (SiO2, Pentane:EtOAc 20:1 to 4:1) to 
afford the desired sulfinamide (312 mg, 1.13 mmol, 70%) which was directly engaged in the next 
step. 
 
4) A solution of the sulfinamide (220 mg, 0.793 mmol) in methanol (1.6 mL) was treated with a 
4N solution of HCl in CPME (0.80 mL, 2.0 mmol, 2.0 equiv) at -78 °C. The reaction mixture was 
then slowly warmed up to rt overnight. Nitrogen was bubbled in the reaction mixture for 10 min 
and then the solvent was removed under reduced pressure and the crude amine salt was triturated 
with cold ether to afford the pure title compound 59 (140 mg, 0.668 mmol, 84% yield) as a white 
solid. 
 
m.p.: 146-147 °C. 
                                                 
10
 Bonazzi, S.; Cheng, B.; Wzorek, J. S.; Evans, D. A. J. Am. Chem. Soc. 2013, 135, 9338. 
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1H NMR (400 MHz, Acetonitrile-d3???????????????, NH), 7.67 ? 7.58 (m, 2H, ArH), 7.45 ? 7.31 
(m, 3H, ArH), 6.14 (ddd, J = 17.2, 10.5, 7.7 Hz, 2H, CH=CH2), 5.45 ? 5.43 (m, 2H, CH=CH2), 
5.43 ? 5.38 (m, 2H, CH=CH2), 4.12 (d, J = 6.8 Hz, 1H, NCH), 4.02 (d, J = 4.7 Hz, 2H, PhCH2). 
13C NMR (101 MHz, CD3???????????, 132.1, 131.5, 130.0, 129.6, 122.67, 63.3, 49.1. 
IR ?max 3391 (w), 3077 (w), 2927 (m), 2854 (w), 1638 (w), 1456 (m), 1301 (w), 1268 (w), 1121 
(w), 996 (m), 923 (s). 
HRMS (ESI) calcd for C12H16N+ [M+H]+ 174.1277; found 174.1277. 
 
 
2-vinylpyrrolidine hydrochloride (61) 
 
Multistep procedure: 
1) DMP (3.56 g, 8.40 mmol, 1.2 equiv) was added portion-wise over 10 min to a stirred solution 
of commercially available tert-butyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate (60) (1.41 g, 
7.00 mmol) in DCM (25 mL). The reaction mixture was stirred at rt for 12 h, then filtered over 
Celite and purified by column chromatography (Pentane:EtOAc 9:1) to afford the desired 
aldehyde (1.21 g, 6.07 mmol, 87%) which was engaged directly in the next step. 
 
2) Following a slightly modified procedure,11 methyltriphenylphosphonium bromide (3.93 g, 11.0 
mmol, 2 equiv) was added to a stirred solution of potassium tert-butoxide (1.23 g, 11.0 mmol, 2 
equiv) in Et2O (25 mL). The reaction mixture was stirred at reflux for 1 h, then cooled down to -5 
°C and a solution of tert-butyl 2-formylpyrrolidine-1-carboxylate (1.10 g, 5.50 mmol) in Et2O (25 
mL) was added over 5 min. The reaction mixture was stirred at rt for 3 h. The reaction mixture 
was quenched with water (20 mL). The layers were separated and the aqueous one extracted with 
ether (3x10 mL). The combined organic layers were washed with brine (20 mL), dried over 
MgSO4, filtered and concentrated under reduced pressure. The crude residue was purified by 
column chromatography (SiO2, Pentane:EtOAc 10:1) to afford the desired olefin (640 mg, 3.24 
mmol, 59% yield) as an oil, which was engaged directly in the next step. 
 
3) Following a slightly modified procedure,12 a 2N HCl solution (4.8 mL, 9.7 mmol, 3 equiv) in 
ether was added to a stirred solution of tert-butyl 2-vinylpyrrolidine-1-carboxylate (640 mg, 3.24 
mmol) in ether (3 mL) at 0 °C. The reaction mixture was stirred at rt for 1 h, then the volatiles 
were removed and the crude was washed with dry ether (3x2 mL) and then dried under high 
vacuum for 1 h to afford the desired amine salt 61 (280 mg, 2.10 mmol, 65%). 
 
1H NMR (400 MHz, CDCl3) ? 10.0 (bs, 1H, NH), 9.48 (bs, 1H, NH), 6.09 (ddd, J = 17.0, 10.3, 
7.6 Hz, 1H, CHCH2), 5.50 (d, 1H, J = 17.1 Hz, CHCH2), 5.38 (d, 1H, J = 10.3 Hz, CHCH2), 
4.12?3.99 (m, 1 H, NCH), 3.48?3.26 (m, 2 H, NCH2), 2.24?1.96 (m, 4 H, 2xCH2). 
13C NMR (101 MHz, Chloroform-d) ? 132.4, 122.0, 62.6, 46.2, 31.2, 24.1. 
Spectra data was consistent with the values reported in literature.13 
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 Morales-Chamorro, M.; Meza-Gonzlez, J.; Cordero-Vargas, A. Tetrahedron Letters, 2015, 56, 4892. 
12
 Donets, P. A.; Van der Eycken, E. V.  Synthesis, 2011, 2147. 
13
 Jurberg, I. D.; Peng, B.; Wöstefeld, E.; Wasserloos, M.; Maulide, N. Angew. Chem., Int. Ed. 2012, 51, 1950. 
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2-vinylpiperidine 2,2,2-trifluoroacetate (63) 
 
Multisptep procedure: 
1) DMP (8.14 g, 19.2 mmol, 1.6 equiv) was added portion-wise over 10 min to a stirred solution 
of commercially available tert-butyl 2-(hydroxymethyl)piperidine-1-carboxylate (62) (2.58 g, 
12.0 mmol) in DCM (60 mL). The reaction mixture was stirred at rt for 12 h, then filtered over 
Celite and purified by column chromatography (EtOAc in pentane 12-20%) to afford the desired 
aldehyde (2.15 g, 10.1 mmol, 84%) which was engaged in the next step. 
 
2) Following a slightly modified procedure,14 methyltriphenylphosphonium bromide (3.95 g, 11.1 
mmol, 2 equiv) was added to a stirred solution of potassium tert-butoxide (1.24 g, 11.1 mmol, 2 
equiv) in Et2O (40 mL). The reaction mixture was stirred at reflux for 1 h, then cooled down to 0 
°C and a solution of the aldehyde (1.18 g, 5.53 mmol) in Et2O (10 mL) was added over 5 min. 
The reaction mixture was stirred at rt for 2 h. The reaction mixture was quenched with water (20 
mL). The layers were separated and the aqueous one extracted with ether (3x10 mL). The 
combined organic layers were washed with brine (20 mL), dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude residue was purified by column chromatography 
(SiO2, Pentane:Et2O 10:1 to 5:1) to afford the desired olefin (1.03 g, 4.87 mmol, 88%) as an oil, 
which was engaged directly in the next step. 
 
3) To a solution of the olefin was added TFA (11.3 mL, 146 mmol, 30 equiv) at 0 °C. The 
reaction mixture was stirred at rt for 3 h and then the volatiles were removed under reduced 
pressure. The crude residue was taken up in water (40 mL). The aqueous layer was washed with 
ether (3x20 mL) and then concentrated under reduced pressure. The crude residue was dried by 
co-evaporation with toluene (3x10 mL) to afford 2-vinylpiperidine 2,2,2-trifluoroacetate (63) 
(1.05 g, 4.66 mmol, 96 %) as an oil as an oil. 
 
1H NMR (400 MHz, CDCl3) ? 9.29 (bs, 1H, NH), 8.76 (bs, 1H, NH), 5.84 (ddd, J = 17.4, 10.5, 
7.1 Hz, 1H, CHCH2), 5.39 (dd, J = 17.4, 1.0 Hz, 1H, CHCH2), 5.31 (d, J = 10.5 Hz, 1H, CHCH2), 
3.54 (q, J = 10.3 Hz, 1H, NCH), 3.37 (d, J = 12.6 Hz, 1H, NCH2), 2.98 ? 2.86 (m, 1H, NCH2), 
1.97 ? 1.88 (m, 2H, 2xNCH2CH2), 1.85 ? 1.70 (m, 3H, 2xNCH2CH2 and NCH2CH2CH2), 1.58 ? 
1.46 (m, 1H, NCH2CH2CH2). 
13C NMR (101 MHz, CDCl3) ? 161.8 (q, J = 36.8 Hz),133.5, 120.7, 116.3 (q, J = 289.2 Hz), 
58.8, 44.6, 28.7, 22.2, 22.0. 
IR ?max 3501 (w), 3015 (w), 2840 (w), 2753 (w), 2533 (w), 2436 (w), 1779 (w), 1670 (s), 1431 
(w), 1177 (s), 1135 (s), 992 (w), 944 (w), 838 (w). 
HRMS (ESI) calcd for C7H14N [M+] 112.1121; found 112.1116 
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 Molander, G. A.; Nichols, P. J. J. Org. Chem. 1996, 61, 6040. 
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Cis-1,3-divinylisoindoline (65) 
 
 
Multistep procedure: 
1) Following a slightly modified procedure,15 isoamyl nitrite (3.22 mL, 23.9 mmol, 2 equiv) was 
slowly added to a stirred solution of 2-aminobenzoic acid (2.050 g, 14.95 mmol, 1.25 equiv) and 
2,2,2-trichloroacetic acid (17 mg, 0.11 mmol, 0.9 mol%) in dry THF (35 mL) at 0 °C for 30 min 
and the mixture was stirred at room temperature for 1.5 h. The dark yellow precipitate of 
benzenediazonium-2-carboxylate was collected by filtration and washed with cold THF using 
minimal suction for draining taking care to prevent complete drying. The salt was immediately 
transferred to a flask. DCE (30 mL) and tert-butyl 1H-pyrrole-1-carboxylate (64) (2.00 g, 12.0 
mmol) were added. The mixture was heated at 60 °C for 45 min and the black mixture was 
cooled to room temperature. After concentration under reduced pressure, the residue was purified 
by flash column chromatography (hexane/ethyl acetate = 95/5) and recrystallization with hexane 
gave tert-butyl 1,4-dihydro-1,4-epiminonaphthalene-9-carboxylate (1.69 g, 6.95 mmol, 58 % 
yield), which was directly used in the next step. 
 
2) Following a slightly modified procedure,16 a 250 mL round-bottom flask equipped with a 
stirring bar and charged with tert-butyl 1,4-dihydro-1,4-epiminonaphthalene-9-carboxylate 
(0.260 g, 1.07 mmol) and dry DCM (105 mL). The flask was put under house vacuum and 
backfilled with nitrogen (3x), then put under vaccum and backfilled with ethylene gas. The 
solution was stirred with an ethylene atmosphere for 30 min and then Grubbs II catalyst (27 mg, 
0.032 mmol, 3 mol%) was added. The reaction was stirred at rt under ethylene atmosphere for 15 
h. Then 2 drops of water were added and solvent was then removed and the product purified by 
column chromatography (Pentane:EtOAc 97:3 to 92:8) affording tert-butyl cis-1,3-
divinylisoindoline-2-carboxylate (238 mg, 0.877 mmol, 82 % yield) as a pale yellow oil, which 
was directly used in the next step. 
 
3) To a solution of tert-butyl cis-1,3-divinylisoindoline-2-carboxylate (0.238 g, 0.978 mmol) in 
dry DCM (3 mL) at 0 °C was slowly added TFA (1.51 mL, 19.6 mmol, 20 equiv). The reaction 
mixture was stirred at rt for 1.5 h and then the volatiles were removed. The crude residue was 
taken up in 1 N NaOH and extracted with DCM (3x10 mL). The combined organic layers were 
dried over MgSO4, filtered and concentrated under reduced pressure. The compound was passed 
through a short plug of silica, eluting with pure ether to afford the title compound cis-1,3-
divinylisoindoline 65 (143 mg, 0.835 mmol, 85 % yield) as an oil. 
 
Rf 0.20 (Pentane:EtOAc 4:1).  
1H NMR (400 MHz, Chloroform-d) ? 7.32 ? 7.26 (m, 2H, ArH), 7.21 ? 7.15 (m, 2H, ArH), 5.92 
(ddd, J = 16.9, 9.9, 7.9 Hz, 2H, CHCH2), 5.38 (dt, J = 17.1, 1.1 Hz, 2H, CHCH2), 5.22 (dd, J = 
10.0, 1.6 Hz, 2H, CHCH2), 4.88 (d, J = 7.8 Hz, 2H, NCH), 2.32 (s, 1H, NH). 
13C NMR (101 MHz, Chloroform-d) ? 142.9, 140.6, 127.4, 123.0, 116.3, 66.2. 
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 Cho, Y.-h.; Zunic, V.; Senboku, H.; Olsen, M.; Lautens, M. J. Am. Chem. Soc. 2006, 128, 6837. 
16
 Bulchert, M.; Meinke, S.; Prenzel, A. H. G. P.; Deppermann, N.; Maison, W. Org. Lett. 2006, 8, 5553. 
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IR ?max 3356 (w), 3075 (w), 2975 (w), 2804 (w), 1638 (w), 1611 (w), 1468 (w), 1420 (w), 1294 
(w), 1060 (w), 994 (m), 925 (s). 
HRMS (ESI) calcd. for C12H14N+ [M+H]+ 172.1121; found 172.1119. 
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5. Preparation of aldimines. 
 
1-((Tert-butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) 
 
Following a slightly modified procedure,17 a 100 mL pressure tube was charged with tert-butyl 
carbamate (7.03 g, 60.0 mmol), 2,2,2-trifluoro-1-methoxyethanol (66) (7.69 mL, 66.0 mmol, 1.1 
equiv), 4Å MS (10 g) and dioxane (80 mL). The tube was sealed under nitrogen atmosphere. The 
resulting mixture was heated at 100 °C for 5 d and then cooled down to rt. The mixture was 
filtered over Celite and the cake was washed with ether (3x20 mL). The volatiles were removed 
under reduced pressure and the resulting solid was recrystallized in chloroform to afford white 
crystals (8.20 g, 38.1 mmol, 64% for 2 crops). 
 
To a solution of pyridine (1.84 mL, 22.8 mmol, 1.4 equiv) and DMAP (50 mg, 0.41 mmol, 2.5 
mol%) in dichloromethane (80 mL) at 0 °C was slowly added acetyl chloride (1.39 mL, 19.5 
mmol, 1.2 equiv). To the resulting mixture was added tert-butyl (2,2,2-trifluoro-1-
hydroxyethyl)carbamate (3.50 g, 16.3 mmol) portion-wise. Then the mixture was stirred at 0 °C 
for 20 min and quenched with water (10 mL). The pH was adjusted to 2 by addition of 0.1 N HCl 
and the layers were separated. The organic layer was washed with 0.1 N HCl (3x20 mL) and 
brine (30 mL), dried over MgSO4, filtered and concentrated under reduced pressure. The crude 
residue was purified by column chromatography (Pentane:EtOAc 10:1) affording  the title 
compound 2a (4.05 g, 15.8 mmol, 97 % yield) as a white solid. 
 
m.p.: 60-61 °C. 
1H NMR (400 MHz, Chloroform-d?????????? 6.57 (m, 1H, CHCF3), 5.48 ? 5.16 (m, 1H, NH), 
2.14 (s, 3H, Me), 1.47 (s, 9H, t-Bu). 
13C NMR (101 MHz, CDCl3?????????, 153.1, 121.8 (q, J = 281.2 Hz), 82.3, 72.1 (q, J = 39.3 Hz), 
28.2, 20.7.  
IR ?max 2984 (w), 1770 (m), 1731 (m), 1522 (w), 1373 (m), 1252 (w), 1199 (s), 1162 (s), 1023 
(m), 837 (w). 
HRMS (ESI) calcd for C9H14F3NNaO4+ [M+Na]+ 280.0767; found 280.0770. 
 
 
2,2,2-Trifluoro-1-((methoxycarbonyl)amino)ethyl acetate (2aa) 
 
Following a slightly modified procedure,17 a 20 mL microwave vial was charged with methyl 
carbamate (2.25 g, 30.0 mmol), 2,2,2-trifluoro-1-methoxyethanol (66) (3.84 mL, 33.0 mmol, 1.1 
equiv), 4Å MS (4 g) and was filled with dioxane (ca 16 mL). The tube was sealed under nitrogen 
atmosphere. The resulting mixture was heated at 100 °C for 5 d and then cooled down to rt. The 
mixture was filtered over Celite and the cake was washed with ethyl acetate (3x20 mL). The 
volatiles were removed under reduced pressure and the residue was purified by column 
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 Ingrassia, L.; Mulliez, M. Synthesis, 1999, 10, 1731. 
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chromatography (SiO2, Pentane:EtOAc 4:1) to afford the title compound (3.93 g, 22.7 mmol, 75 
% yield) as a white solid. 
 
To a solution of pyridine (1.96 mL, 24.3 mmol, 1.4 equiv) and DMAP (53 mg, 0.43 mmol, 2.5 
mol%) in dichloromethane (87 mL) at 0 °C was slowly added acetyl chloride (1.48 mL, 20.8 
mmol, 1.2 equiv). To the resulting mixture was added methyl (2,2,2-trifluoro-1-
hydroxyethyl)carbamate (3.00 g, 17.3 mmol) portionwise. Then the mixture was stirred at 0 °C 
for 20 min and quenched with water (10 mL). The pH was adjusted to 2 by addition of 0.1 N HCl 
and the layers were separated. The organic layer was washed with 0.1 N HCl (3x20 mL) and 
brine (30 mL), dried over MgSO4, filtered and concentrated under reduced pressure. The crude 
residue was purified by column chromatography (Pentane:EtOAc 5:1) affording the title 
compound 2aa (3.55 g, 16.5 mmol, 95 % yield) as a white solid. 
 
Rf 0.50 (Pentane:EtOAc 3:1). 
m.p.: 84-86 °C. 
1H NMR (400 MHz, Chloroform-d) ???.90 ? 6.66 (m, 1H, CHCF3), 5.77 ? 5.40 (m, 1H, NH), 
3.76 (s, 3H, OMe), 2.14 (s, 2H, Ac). 
13C NMR (101 MHz, CDCl3????????1, 154.9, 121.7 (q, J = 281.0 Hz), 72.3 (q, J = 36.9 Hz), 53.4, 
20.6.  
IR ?max 3316 (w), 2996 (w), 2961 (w), 2225 (w), 1767 (s), 1732 (m), 1538 (m), 1381 (m), 1254 
(s), 1208 (s), 1162 (s), 1029 (s), 966 (m). 
HRMS (ESI) calcd for C6H8F3NNaO4+ [M+Na]+ 238.0298; found 238.0299.  
 
 
4-((1-Ethoxy-2,2,2-trifluoroethyl)amino)benzonitrile (2f) 
 
A round-bottomed flask equipped with a reflux condenser and a magnetic stirring bar was 
charged with 1-ethoxy-2,2,2-trifluoroethanol (67) (2.20 mL, 16.1 mmol, 3.35 equiv) and ethanol 
(10 mL). Then 4-aminobenzonitrile (68) (0.567 g, 4.80 mmol) and PTSA (0.052 g, 0.30 mmol, 
6.3 mol%) were added to the reaction flask, and the mixture was stirred at reflux. After the 
reaction was complete (monitoring by TLC, Pentane:EtOAc 4:1), and cooled to room 
temperature, 10% aqueous NaHCO3 (30 mL) was added. The mixture was extracted with ethyl 
acetate (2x30 mL), dried over MgSO4. The solvent was removed under reduced pressure and the 
residue was purified by column chromatography on Biotage (SNAP cartridge KP-SIL 50 g, 95:5 
Pentane:EtOAc to 60:40 Pentane:EtOAc) to afford the title compound 2f (1.05 g, 4.30 mmol, 90 
% yield) as a white solid. 
 
Rf 0.60 (Pentane:EtOAc 4:1). 
m.p.: 94-96 °C. 
1H NMR (400 MHz, Chloroform-d) ??7.55 ? 7.43 (m, 2H, ArH), 6.84 ? 6.73 (m, 2H, ArH), 5.10 
(dq, J = 9.5, 4.6 Hz, 1H, CF3CH), 4.87 (d, J = 9.5 Hz, 1H, NH), 3.75 (dq, J = 9.3, 7.1 Hz, 1H, 
OCH2), 3.66 (dq, J = 9.2, 7.0 Hz, 1H, OCH2), 1.22 (t, J = 7.0 Hz, 3H, Me). 
13C NMR (101 MHz, CDCl3) ??????4, 134.0, 122.7 (q, J = 283.7 Hz), 119.6, 114.1, 102.4, 81.2 
(q, J = 34.1 Hz), 65.0, 15.0. 
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IR ?max 3342 (w), 2985 (w), 2220 (m), 1609 (s), 1525 (m), 1328 (w), 1259 (m), 1176 (s), 1140 
(s), 1092 (s), 913 (w), 829 (m). 
HRMS (ESI) calcd for C11H12F3N2O+ [M+H]+ 245.0896; found 245.0893.  
 
N-(1-Ethoxy-2,2,2-trifluoroethyl)-4-nitrobenzenesulfonamide (2h)18 
 
Following a slightly modified procedure,19 a round-bottomed flask equipped with a magnetic 
stirring bar under nitrogen atmosphere was charged with 4-nitrobenzenesulfonamide (69) (2.02 g, 
10.0 mmol) and DCM (20 mL). Then 1-ethoxy-2,2,2-trifluoroethanol (67) (1.53 mL, 11.0 mmol, 
1.1 equiv) and TiCl4 (2.21 mL, 20.0 mmol, 2 equiv) were added dropwise. The resulting mixture 
was stirred at 80 °C for 15 h and then treated with ethanol (3.50 mL, 60.0 mmol, 6 equiv). The 
crude residue was purified by column chromatography (SiO2, Pentane:EtOAc 3:1) to afford the 
title compound 2h (1.45 g, 4.42 mmol, 44%) as a white solid. 
Rf 0.20 (Pentane:EtOAc 3:1). 
m.p.: 92-93 °C. 
1H NMR (400 MHz, Chloroform-d) ??8.48 ? 8.28 (m, 2H, ArH), 8.20 ? 7.91 (m, 2H, ArH), 5.42 
(d, J = 9.9 Hz, 1H, NH), 5.03 (dq, J = 9.9, 4.5 Hz, 1H, CF3CH), 3.88 (dq, J = 9.5, 7.0 Hz, 1H, 
OCH2), 3.70 (dq, J = 9.5, 7.0 Hz, 1H, OCH2), 1.23 (t, J = 7.0 Hz, 3H, Me). 
13C NMR (101 MHz, CDCl3????150.4, 146.3, 128.3, 124.6, 121.7 (d, J = 282.6 Hz), 81.6 (q, J = 
35.6 Hz), 66.0, 14.7. 
IR ?max 3282 (w), 2987 (w), 2895 (w), 1610 (w), 1534 (s), 1454 (w), 1351 (s), 1313 (m), 1276 
(m), 1169 (s), 1109 (s), 1065 (s), 936 (m), 856 (m). 
 
 
2,2,2-Trifluoro-1-((methoxycarbonyl)amino)ethyl acetate (2i) 
 
Following a slightly modified procedure,20 a 25 mL round-bottom flask was charged with 
acetamide (1.18 g, 20.0 mmol), 2,2,2-trifluoro-1-methoxyethanol (66) (2.56 mL, 22.0 mmol, 1.1 
equiv), 4Å MS (3 g) and dioxane (10 mL) and then sealed under nitrogen atmosphere. The 
resulting mixture was heated at 100 °C for 5 d. The mixture was filtered over Celite and the cake 
was washed with ethylacetate. The volatiles were removed under reduced pressure. The residue 
was dried under a nitrogen flow overnight. DCM (40 mL) was added and heated to reflux. The 
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 The molecule ion could not be observed by high resolution mass spectrometry.  
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 Kumadaki, I.; Jonoshita, S.; Harada, A.; Omote, M.; Ando, A. J. Fluorine Chem. 1999, 97, 61 
20
 Tanaka, K.; Ishiguro, Y.; Mitsuhashi, K. Bull. Chem. Soc. Jpn. 1993, 66, 661. 
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mixture was filtered. The mother liquor was concentrated to half its volume and filtered again. 
The solids were combined affording N-(2,2,2-trifluoro-1-hydroxyethyl)acetamide (1.51 g, 9.61 
mmol, 48%) as a white solid. 
 
Acetyl chloride (1.8 mL, 26 mmol, 4 equiv) was slowly added to a solution of pyridine (2.3 mL, 
29 mmol, 4.5 equiv) and DMAP (39 mg, 0.32 mmol, 5 mol%) in dichloromethane (50 mL) at 0 
°C. To the resulting mixture was added N-(2,2,2-trifluoro-1-hydroxyethyl)acetamide (1.00 g, 
6.37 mmol) portionwise. Then the mixture was stirred at 0 °C for 20 min and quenched with 
water (10 mL). The pH was adjusted to 2 by addition of 0.1 N HCl and the layers were separated. 
The organic layer was washed with 0.1 N HCl (3x20 mL) and brine (30 mL), dried over MgSO4, 
filtered and concentrated under reduced pressure. The crude residue was recrystallized in DCM to 
afford the title compound 2i (860 mg, 4.32 mmol, 68%) as a white solid. 
 
m.p.: 123-126 °C. 
1H NMR (400 MHz, Chloroform-d????7.00 (dq, J = 10.4, 5.3 Hz, 1H, CF3CH), 6.44 ? 6.33 (m, 
1H, NH), 2.14 (s, 3H, OAc), 2.09 (s, 3H, NAc). 
13C NMR (101 MHz, CDCl3????169.5, 167.9, 121.9 (q, J = 280.9 Hz), 69.8 (q, J = 36.8 Hz), 23.2, 
20.5. 
IR ?max 3280 (m), 3058 (w), 1759 (s), 1680 (s), 1545 (m), 1433 (w), 1382 (m), 1259 (s), 1219 (s), 
1164 (s), 1050 (m), 978 (m), 914 (w). 
HRMS (ESI) calcd for C6H8F3NNaO3 [M+Na] 222.0354; found 222.0359. 
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6. Preparation of bromoalkynes. 
 
General procedure for the bromination of terminal alkynes:21  
 
The terminal alkyne (1.0 equiv) is dissolved in acetone (ca. 6.8 mL per mmol of alkyne). N-
bromosuccinimide (1.2 equiv) and AgNO3 (0.1 equiv) are added to the resulting solution in this 
order and the mixture is stirred at rt for 3-6 hours, until complete consumption of the starting 
material according to TLC. It was then poured onto iced water. The aqueous layer was extracted 
with pentane (3 times) and the combined organic extracts were dried over MgSO4, filtered and 
the solvent removed by evaporation under reduced pressure. The bromo alkyne was isolated by 
column chromatography in 95-99% purity as judged by 1H NMR. 
 
2-Bromo-1-triisopropylsilyl acetylene (3) 
 
Triisopropylsilylacetylene (70) (813 mg, 4.45 mmol, 1.00 equiv) was brominated according to 
the general procedure. Bromoalkyne 3 was obtained as a colorless oil (1.16 g, 4.43 mmol, 99%) 
without further purification.  
1H NMR (400 MHz, CDCl3) ? 1.20-0.97 (m, 21 H, TIPS). 
13C NMR (100 MHz, CDCl3) ? 83.5, 61.7, 18.5, 11.3. 
Spectra data was consistent with the values reported in literature.21 
 
((4-Bromo-2-methylbut-3-yn-2-yl)oxy)triisopropylsilane (73) 
 
 Following a reported procedure,22 2-methylbut-3-yn-2-ol (71) (0.34 mL, 3.5 mmol, 1.0 
equiv.) and 2,6-lutidine (freshly distilled on CaH2, 0.41 mL, 3.5 mmol, 1.0 equiv.) were dissolved 
in CH2Cl2 (12 mL). TIPSOTf (0.94 mL, 3.5 mmol, 1.0 equiv.) was added dropwise to the solution 
at 0 °C. The solution was allowed to warm to rt overnight and then quenched with a saturated 
aqueous NaHCO3 solution and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The 
combined organic layers were washed with H2O, dried over MgSO4, filtered and the solvent was 
removed in vacuo. Purification by column chromatography (SiO2, pentane) afforded TIPS-
protected propargyl alcohol 72 as a colorless oil (622 mg, 2.59 mmol, 74% yield), which was 
used directly for the next step. 
 Following a reported procedure,6 propargyl alcohol 72 (603 mg, 2.51 mmol, 1.0 equiv) 
was dissolved in acetone (17 mL). N-bromosuccinimide (535 mg, 3.01 mmol, 1.2 equiv) and 
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 Jiang, M. X.; Rawat, M.; Wulff, W. D. J. Am. Chem. Soc., 2004, 126, 5970. 
22
 Nishimura, T.; Nagaosa, M.; Hayashi, T. Tetrahedron Lett. 2011, 52, 2185. 
S21 
 
AgNO3 (42 mg, 0.25 mmol, 0.1 equiv) are added to the resulting solution in this order and the 
mixture is stirred at rt for 6 hours, until complete consumption of the starting material according 
to TLC. It was then poured onto iced water. The aqueous layer was extracted with pentane (3 
times) and the combined organic extracts were dried over MgSO4, filtered and the solvent 
removed by evaporation under reduced pressure. After purification by column chromatography 
(SiO2, pentane), bromoalkyne 73 was obtained as a colorless oil (733 mg, 2.30 mmol, 91% 
yield).in 95% purity as judged by 1H NMR. 
1H NMR (400 MHz, CDCl3) ? 1.51 (s, 6 H), 1.18-1.03 (m, 21 H). 
13C NMR (100 MHz, CDCl3) ? 85.4, 67.2, 42.7, 32.9, 18.3, 13.0. 
Spectra data was consistent with the values reported in literature.Error! Bookmark not defined. 
 
(((4-Bromo-2-methylbut-3-yn-2-yl)oxy)methyl)benzene (75)  
 
Following a reported procedure,23 NaH (60% suspension in mineral oil, 240 mg, 6.00 mmol, 1.2 
equiv) was added portionwise to a solution of 2-methyl-3-butyn-2-ol (71) (0.49 mL, 5.0 mmol, 
1.0 equiv) in THF (24 mL). The mixture was stirred at rt for 1 hour and then TBAI (92.0 mg, 
0.250 mmol, 0.050 equiv) and benzyl bromide (0.72 mL, 6.0 mmol, 1.2 equiv) were added in this 
order. The reaction mixture was stirred at rt overnight and then diluted with Et2O (18 mL). The 
organic solution was washed with water (3 x 15 mL), brine and dried over MgSO4. Upon 
filtration, it was concentrated by evaporation under reduced pressure and the resulting crude oil 
was purified by column chromatography (SiO2, Pentane/Et2O 95/5) to afford the pure O-
benzylated alcohol 74 as a colorless oil (715 mg, 4.10 mmol, 82% yield) which was directly used 
in the next step. 
 O-Benzylated alcohol 74 (523 mg, 3.00 mmol) was brominated according to the general 
procedure. After purification by column chromatography (SiO2, Pentane/EtOAc 98/2), 
bromoalkyne 75 was obtained as a pale yellow oil (631 mg, 2.49 mmol, 83% yield).  
1H NMR (400 MHz, CDCl3) ? 7.41-7.31 (m, 4 H), 7.27 (m, 1 H), 4.62 (s, 2 H), 1.55 (s, 6 H).  
13C NMR (101 MHz, CDCl3) ? 138.7, 128.3, 127.7, 127.4, 82.4, 71.7, 66.7, 44.1, 28.7. 
Spectra data was consistent with the values reported in literature.Error! Bookmark not defined.  
 
((1-Bromonon-1-yn-3-yl)oxy)triisopropylsilane (78) 
 
 
 
Following a slightly modified reported procedure,24 heptaldehyde (76) (1.22 mL, 8.76 mmol, 1.0 
equiv.) was added dropwise to a solution of ethynyl magnesium bromide (0.5 M in THF, 22.8 
                                                 
23
 Trost, B. M.; Fandrick, D. R.; Dinh, D. C. J. Am. Chem. Soc. 2005, 127, 14186. 
24
 Buzas, A.; Gagosz, F. J. Am. Chem. Soc. 2006, 128, 12614. 
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mL, 11.4 mmol, 1.3 equiv.) at 0 °C. After 30 min, the cooling bath was removed to reach rt and 
the solution was stirred for further 2 h. The reaction was then quenched by addition of aqueous 
HCl (1.0 M, 15 mL) and the mixture was extracted with Et2O (3 x 20 mL). The combined organic 
layers were washed with brine, dried over MgSO4, filtered and the solvent was removed under 
reduced pressure. Purification by column chromatography (SiO2, pentane/EtOAc 20/1) afforded 
the corresponding propargyl alcohol as a yellow oil (943 mg, 6.73 mmol, 77% yield).  
   
TIPSCl (1.36 mL, 6.36 mmol, 1.1 equiv.) and DMAP (777 mg, 6.36 mmol, 1.1 equiv.) were 
dissolved in CH2Cl2 (10 mL) at rt and a solution of propargyl alcohol (810 mg, 5.78 mmol, 1.0 
equiv.) in CH2Cl2 (30 mL) was slowly added to the reaction mixture. The reaction was stirred 
overnight and then quenched by sequential addition of H2O (36 mL) and aqueous HCl (2.0 M, 36 
mL). The mixture was extracted with CH2Cl2 (3 x 20 mL) and the combined organic layers were 
washed with brine, dried over MgSO4, filtered and the solvent was removed in vacuo. 
Purification by column chromatography (SiO2, Pentane) afforded the O-silylated propargyl 
alcohol 77 as a colorless oil (1.04 g, 3.51 mmol, 61% yield).  
 O-Silylated propargyl alcohol 77 (890 mg, 3.00 mmol, 1.0 equiv.) was brominated 
according to the general procedure. After purification by column chromatography (SiO2, 
pentane), bromo alkyne 78 was obtained as a colorless oil (1.04 g, 2.77 mmol, 92% yield). 
1H NMR (400 MHz, CDCl3) ? 4.48 (t, 1 H, J = 6.3 Hz), 1.69 (m, 2 H), 1.44 (m, 2 H), 1.36-1.26 
(m, 6 H), 1.17-1.04 (m, 21 H), 0.89 (t, J = 6.7 Hz). 
13C NMR (101 MHz, CDCl3) ? 82.1, 64.0, 43.6, 38.7, 31.8, 29.0, 24.9, 22.6, 18.0, 18.0, 14.1, 
12.3. 
Spectra data was consistent with the values reported in literature.Error! Bookmark not defined. 
 
((4-Bromo-1,1,1-trifluoro-2-phenylbut-3-yn-2-yl)oxy)(tert-butyl)dimethylsilane (81)18 
 
 
 
To a 0.5 M solution of ethynylmagnesium bromide (7.0 mL, 3.5 mmol) in THF was slowly added 
2,2,2-trifluoro-1-phenylethanone (79) (300 mg, 1.72 mmol) in THF (1 mL). After 3 h at rt the 
reaction mixture was quenched with water (1 mL) and then NH4Cl sat solution was added (5 mL) 
and the mixture was diluted with DCM (10 mL). The layers were separated and the aqueous layer 
was extracted once with DCM (10 mL). The combined organic layers were dried over MgSO4, 
filtered and concentrated under reduced pressure to afford a yellow oil that was engaged in the 
next step without further purification.  
  
TBS-Cl (0.422 g, 2.80 mmol, 1.4 equiv) was slowly added to a solution of the alcohol (0.400 g, 
2.00 mmol), DBU (0.452 mL, 3.00 mmol, 1.5 equiv), DMAP (12 mg, 0.10 mmol, 0.05 equiv) in 
acetonitrile (6 mL) at 0 °C. The reaction mixture was stirred for 12 h at rt. The reaction mixture 
was quenched with water (5 mL) and extracted with DCM (3x5 mL). The combined organic 
layers were dried over MgSO4, filtered and concentrated under reduced pressure. The crude 
residue was purified by column chromatography (SiO2, Pentane) to afford compound 80 (0.460 g, 
1.46 mmol, 73 % yield) as a clear oil that was directly engaged in the next step. 
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O-Silylated propargyl alcohol 80 (450 mg, 1.43 mmol, 1.0 equiv.) was brominated according to 
the general procedure. After purification by column chromatography (SiO2, pentane), bromo 
alkyne 81 was obtained as a colorless oil (531 mg, 1.35 mmol, 94% yield). 
 
Rf 0.6 (pentane). 
1H NMR (400 MHz, CDCl3) ? 7.76 ? 7.64 (m, 2H, ArH), 7.46 ? 7.34 (m, 3H, ArH), 0.98 (s, 9H, 
t-Bu), 0.25 (s, 3H, Me), 0.03 (s, 3H, Me). 
13C NMR (101 MHz, CDCl3) ? 136.9, 129.5, 128.1, 127.5, 123.1 (q, J = 286.3 Hz), 76.7, 75.4 (q, 
J = 32.5 Hz), 51.2, 25.9, 18.5, -3.4, -3.4. 
IR ?max 2955 (w), 2860 (w), 2207 (w), 1473 (w), 1264 (m), 1179 (s), 1146 (m), 1081 (s), 942 
(m), 863 (s), 841 (s). 
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7. Pd-catalyzed tandem aminal formation carbo-amination of allylamines. 
 
General procedure A 
To an oven-dried 5 mL microwave tube under nitrogen atmosphere was added the aldimine 
(0.330 mmol, 1.1 equiv) and cesium carbonate (225 mg, 0.690 mmol, 2.3 equiv). The tube was 
sealed evacuated and backfilled with nitrogen (this was repeated for a total of 3 times). Then dry 
degassed toluene was added (0.45 mL) followed by allylamine (0.300 mmol, 1.00 equiv). The 
resulting mixture was stirred for 30 min at 70 °C. Then (bromoethynyl)triisopropylsilane (3) (102 
mg, 0.390 mmol) was added and a premixed solution of Pd2dba3 (5.5 mg, 6.0 µmol) and Tri(2-
furyl)phosphine (8.4 mg, 0.036 mmol) in toluene (0.45 mL). The resulting mixture was stirred for 
20 h at 60-70 °C in an oil bath, then cooled down, filtered over Celite eluting with Et2O and 
concentrated under reduced pressure to half its volume and directly purified by column 
chromatography using the indicated solvents.  
 
General procedure B for ?-branched allylamines 
To an oven-dried 5 mL microwave tube under nitrogen atmosphere was added the aldimine 
(0.330 mmol, 1.1 equiv), CsOTf (102 mg, 0.360 mmol, 1.2 equiv) and cesium carbonate (225 
mg, 0.690 mmol, 2.3 equiv). The tube was sealed, evacuated and backfilled with nitrogen (this 
was repeated for a total of 3 times). Then dry degassed toluene was added (0.45 mL) followed by 
allylamine (0.300 mmol, 1.00 equiv). The resulting mixture was stirred for 1 to 4 h at 70 °C. 
Then (bromoethynyl)triisopropylsilane (3) (102 mg, 0.390 mmol) was added and a premixed 
solution of Pd2dba3 (11 mg, 12 µmol) and Tri(2-furyl)phosphine (17 mg, 0.072 mmol) in toluene 
(0.45 mL). The resulting mixture was stirred for 20 h at 70 °C in an oil bath, then cooled down, 
filtered over Celite eluting with Et2O and concentrated under reduced pressure to half its volume 
and directly purified by column chromatography using the indicated solvents.  
 
General procedure C for 1,1-disubstituted olefins 
To an oven-dried 5 mL microwave tube under nitrogen atmosphere was added the aldimine and 
cesium carbonate (225 mg, 0.690 mmol, 2.3 equiv). The tube was sealed, evacuated and 
backfilled with nitrogen (this was repeated for a total of 3 times). Then dry degassed toluene was 
added (0.45 mL) followed by allylamine (0.300 mmol, 1.00 equiv). The resulting mixture was 
stirred for 1 to 4 h at 70 °C. Then the bromo derivative was added and a premixed solution of 
Pd2dba3 (11 mg, 12 µmol) and PhDavePhos (23 mg, 0.060 mmol) in toluene (0.45 mL). The 
resulting mixture was stirred for 20 h at 70 °C in an oil bath, then cooled down, filtered over 
Celite eluting with Et2O and concentrated under reduced pressure to half its volume and directly 
purified by column chromatography using the indicated solvents.  
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General procedure D for aryl and vinyl bromides 
To an oven-dried 5 mL microwave tube under nitrogen atmosphere was added the aldimine 
(0.330 mmol, 1.1 equiv), CsOTf (102 mg, 0.360 mmol, 1.2 equiv) and cesium carbonate (239 
mg, 0.735 mmol, 2.45 equiv). The tube was sealed, evacuated and backfilled with nitrogen (this 
was repeated for a total of 3 times). Then dry degassed toluene was added (0.50 mL) followed by 
allylamine (0.300 mmol, 1.00 equiv). The resulting mixture was stirred for 30 min at 70 °C. Then 
the aryl or vinyl bromide (0.450 mmol, 1.5 equiv) was added and a premixed solution of Pd2dba3 
(11 mg, 12 µmol) and Tri(2-furyl)phosphine (17 mg, 0.072 mmol) in toluene (0.50 mL). The 
resulting mixture was stirred for 20 h at 70 °C in an oil bath, then cooled down, filtered over 
Celite eluting with Et2O and concentrated under reduced pressure to half its volume and directly 
purified by column chromatography using the indicated solvents.  
NB: when a solid aryl bromide was used, it was added in solution in toluene. 
 
The stereochemistry of the imidazolidines was assigned by analogy with compounds 16, 19 and 
22 for which 2D ROESY and 1D NOESY experiments were performed. 
 
Tert-butyl 3-benzyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)imidazolidine-
1-carboxylate (4) 
 
Following General Procedure A, the title compound was prepared 
from N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 1-
((tert-butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) (85 
mg, 0.33 mmol, 1.1 equiv) and (bromoethynyl)triisopropylsilane 
(3) (102 mg, 0.390 mmol, 1.3 equiv). The crude oil was purified by 
column chromatography on Biotage (SNAP cartridge KP-SIL 25 g, 
92:8 to 40:60 Pentane:CH2Cl2) affording the title compound 4 (150 
mg, 0.286 mmol, 95 % yield, dr > 20:1 in the crude 19F NMR) as a 
pale yellow oil. 
 
Rf 0.40 (Pentane/CH2Cl2 2/1). 
1H NMR (400 MHz, CDCl3) ???????? 7.28 (m, 5H, ArH), 5.11 ? 4.74 (m, 1H, CHCF3), 4.16? 
3.90 (m, 1H, CHN), 3.90 ? 3.77 (m, 2H, PhCH2), 3.27 (app d, J = 7.5, 2H, CH2N), 3.00 (bs, 1H, 
CH2CC), 2.30 (dd, J = 16.4, 10.5 Hz, 1H, CH2CC), 1.49 (s, 9H, Boc), 1.07 ? 0.99 (m, 21H, 
TIPS). 
13C NMR (101 MHz, CDCl3) ??????2, 137.2, 128.9, 128.7, 128.0, 124.3 (q, J = 284.4 Hz), 104.4, 
82.6, 81.6, 77.4 (q, J = 33.5 Hz), 60.0, 57.1, 56.1, 28.3, 25.1, 18.7, 11.3. 
19F NMR (376 MHz, CDCl3) ? -76.7. 
IR ?max 2942 (m), 2867 (m), 2175 (w), 1707 (s), 1464 (w), 1375 (s), 1155 (s), 913 (m). 
HRMS calcd for C28H44F3N2O2Si+ [M+H]+ 525.3119; found 525.3119. 
 
 
Methyl 3-benzyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)imidazolidine-1-
carboxylate (5) 
 
Following General Procedure A, the title compound was prepared 
from N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 2,2,2-
trifluoro-1-((methoxycarbonyl)amino)ethyl acetate (2aa) (71 mg, 0.33 
mmol, 1.1 equiv) and (bromoethynyl)triisopropylsilane (3)  (102 mg, 
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0.390 mmol, 1.3 equiv). The crude oil was purified by column chromatography (SiO2 2:1 
Pentane: CH2Cl2) affording the title compound 5 (136 mg, 0.282 mmol, 94% yield, dr > 20:1 in 
the crude 19F NMR) as a clear oil. 
 
Rf 0.20 (Pentane/CH2Cl2 2/1). 
1H NMR (400 MHz, CDCl3) ???????? 7.27 (m, 5H, ArH), 5.15 ? 4.77 (m, 1H, CHCF3), 4.06? 
3.93 (m, 1H, CHN), 3.87 (d, J = 13.2 Hz, 1H, PhCH2), 3.79 (d, J = 13.2 Hz, 1H, CH2Ph), 3.75 (s, 
3H, CH3O), 3.26 (app. dd, J = 7.7, 1.6 Hz, 2H, CH2N), 2.97 (m, 1H, CH2CC), 2.31 (dd, J = 16.4, 
10.5 Hz, 1H, CH2CC), 1.31 ? 0.80 (m, 21H, TIPS). 
13C NMR (101 MHz, CDCl3) 155.6, 137.1, 128.9, 128.7, 128.0, 124.1 (q, J = 284.3 Hz), 104.1, 
82.9, 77.5 (m), 59.9, 57.2, 56.2, 53.3, 25.0, 18.7, 11.3. 
19F NMR (376 MHz, CDCl3) ? -76.7.  
IR ?max 2949 (m), 2866 (m), 2175 (w), 1723 (s), 1450 (m), 1360 (s), 1140 (s), 989 (m), 882 (w). 
HRMS calcd for C25H38F3N2O2Si+ [M+H]+ 483.2649; found 483.2641. 
 
 
Methyl 2-(trifluoromethyl)-3-(4-(trifluoromethyl)benzyl)-5-(3-(triisopropylsilyl)prop-2-yn-
1-yl)imidazolidine-1-carboxylate (6) 
Following General Procedure A, the title compound was prepared 
from N-(4-(trifluoromethyl)benzyl)prop-2-en-1-amine (50) (64.6 
mg, 0.300 mmol), 2,2,2-trifluoro-1-
((methoxycarbonyl)amino)ethyl acetate (2aa) (71 mg, 0.33 mmol, 
1.1 equiv) and (bromoethynyl)triisopropylsilane (3) (102 mg, 
0.390 mmol, 1.3 equiv). The crude oil was purified by column 
chromatography (SiO2 2:1 Pentane:CH2Cl2) affording the title 
compound 6 (156 mg, 0.283 mmol, 94% yield, dr > 20:1 in the 
crude 19F NMR) as a pale yellow oil. 
 
Rf 0.50 (Pentane/CH2Cl2 1/1). 
1H NMR (400 MHz, CDCl3) ??7.60 (d, J = 8.1 Hz, 2H, ArH), 7.46 (d, J = 8.0 Hz, 2H, ArH), 5.02 
? 4.81 (m, 1H, CHCF3), 4.23 ? 4.04 (m, 1H, CHN), 3.97 (d, J = 13.3 Hz, 1H, ArCH2), 3.82 (d, J 
= 13.5 Hz, 1H, ArCH2), 3.77 (s, 3H, CH3O), 3.26 (dd, J = 11.6, 7.0 Hz, 1H, CH2N), 3.15 (dd, J = 
11.6, 7.7 Hz, 1H, CH2N), 3.06 ? 2.87 (m, 1H, CH2CC), 2.35 (dd, J = 16.4, 10.5 Hz, 1H, CH2CC), 
1.09 ? 0.95 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) ? 155.7, 141.4, 130.3 (q, J = 32.4 Hz), 129.0, 125.7 (q, J = 
3.8 Hz), 124.4 (q, J = 272.2 Hz), 124.2 (q, J = 284.2 Hz), 104.0, 83.2, 77.5 (m, overlapping with 
chloroform signals), 59.2, 57.2, 56.2, 53.5, 25.0, 18.7, 11.3. 
19F NMR (376 MHz, CDCl3) ? -62.6, -76.5. 
IR ?max 2960 (m), 2871 (m), 2175 (w), 1724 (s), 1453 (m), 1368 (m), 1323 (s), 1170 (s), 1137 (s), 
1074 (m). 
HRMS calcd. for C26H37F6N2O2Si+ [M+H]+ 551.2523; found 551.2528. 
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Methyl 3-(4-formylbenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)imidazolidine-1-carboxylate (7) 
 
Following General Procedure A, the title compound was 
prepared from freshly purified 4-
((allylamino)methyl)benzaldehyde (52) (52.6 mg, 0.300 mmol), 
2,2,2-trifluoro-1-((methoxycarbonyl)amino)ethyl acetate (2aa) 
(71 mg, 0.33 mmol, 1.1 equiv) and 
(bromoethynyl)triisopropylsilane (3) (102 mg, 0.390 mmol, 1.3 
equiv). The crude oil was purified by column chromatography 
on Biotage (SNAP cartridge KP-SIL 25 g, 60:40 to 0:100 
Pentane:CH2Cl2) affording the title compound 7 (142 mg, 0.278 
mmol, 93% yield, dr > 20:1 in the crude 19F NMR) as a yellow oil. 
 
Rf 0.25 (Pentane/CH2Cl2 1/2). 
1H NMR (400 MHz, CDCl3) ?????? (s, 1H, CHO), 7.90 ? 7.82 (m, 2H, ArH), 7.56 ? 7.47 (m, 2H, 
ArH), 5.07 ? 4.78 (m, 1H, CHCF3), 4.25 ? 4.04 (m, 1H, CHN), 3.98 (d, J = 13.8 Hz, 1H, ArCH2), 
3.86 (d, J = 13.8 Hz, 1H, ArCH2), 3.77 (s, 3H, CH3O), 3.28 (dd, J = 11.9, 7.2 Hz, 1H, CH2N), 
3.17 (dd, J = 11.9, 7.3 Hz, 1H, CH2N), 3.10 ? 2.85 (m, 1H, CH2CC), 2.35 (dd, J = 16.4, 10.5 Hz, 
1H, CH2CC), 0.99 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) ? 191.9, 155.7, 144.3, 136.2, 130.2, 129.2, 124.0 (q, J = 
284.2 Hz), 103.9, 83.2, 77.6 (m overlapping with chloroform signals), 59.5, 57.4, 56.2, 53.5, 
25.0, 18.7, 11.3. 
19F NMR (376 MHz, CDCl3) ? -76.5. 
IR ?max 2948 (w), 2865 (w), 2176 (w), 1714 (s), 1453 (m), 1365 (m), 1289 (m), 1176 (s), 1143 
(s), 915 (w). 
HRMS calcd. for C26H37F3N2NaO3Si+ [M+Na]+ 533.2418; found 533.2425. 
 
 
Methyl 3-(4-bromobenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)imidazolidine-1-carboxylate (8) 
Following General Procedure A, the title compound was prepared 
from N-(4-bromobenzyl)prop-2-en-1-amine (67.8 mg, 0.300 mmol), 
2,2,2-trifluoro-1-((methoxycarbonyl)amino)ethyl acetate (2aa) (71 
mg, 0.33 mmol, 1.1 equiv) and (bromoethynyl)triisopropylsilane (3) 
(102 mg, 0.390 mmol, 1.3 equiv). The crude oil was purified by 
column chromatography (SiO2 5:2 to 2:1 Pentane:CH2Cl2) affording 
the title compound 8 (148 mg, 0.264 mmol, 88% yield, dr > 20:1 in 
the crude 19F NMR) as a pale yellow oil. 
 
Rf 0.48 (Pentane/CH2Cl2 1/1). 
1H NMR (400 MHz, CDCl3) ???????? 7.42 (m, 2H, ArH), 7.23 ? 7.16 (m, 2H, ArH), 5.04 ? 4.77 
(m, 1H, CHCF3), 4.22 ? 3.97 (m, 1H, CHN), 3.83(d, J = 13.6 Hz, 1H, ArCH2), 3.75 (s, 3H, 
CH3O), 3.72 (d, J = 13.6 Hz, 1H, ArCH2), 3.25 (dd, J = 12.1, 7.3 Hz, 1H, CH2N), 3.17 (dd, J = 
12.1, 7.3 Hz, 1H, CH2N), 3.03 ? 2.87 (m, 1H, CH2CC), 2.32 (dd, J = 16.4, 10.4 Hz, 1H, , 
CH2CC), 1.10 ? 0.93 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) ? 155.7, 136.2, 131.8, 130.4, 124.2 (q, J = 283.9 Hz), 121.9, 
104.0, 83.1, 77.5 (m overlapping with chloroform signals), 59.1, 57.1, 56.1, 53.4, 25.0, 18.6, 
11.3. 
S28 
 
19F NMR (376 MHz, CDCl3) ? -76.6. 
IR ?max 2951 (m), 2866 (m), 2175 (w), 1719 (s), 1448 (s), 1364 (s), 1175 (s), 1143 (s). 
HRMS calcd. for C25H3779BrF3N2O2Si+ [M+H]+ 561.1754; found 561.1751. 
 
 
Methyl 3-(2-chlorobenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)imidazolidine-1-carboxylate (9) 
Following General Procedure A, the title compound was prepared 
from N-(2-chlorobenzyl)prop-2-en-1-amine (54.5 mg, 0.300 mmol), 
2,2,2-trifluoro-1-((methoxycarbonyl)amino)ethyl acetate (2aa) (71 
mg, 0.33 mmol, 1.1 equiv) and (bromoethynyl)triisopropylsilane (3) 
(102 mg, 0.390 mmol 1.3 equiv). The crude oil (dr 16.5:1 in the crude 
19F NMR) was purified by column chromatography on Biotage (SNAP 
cartridge KP-SIL 25 g, 92:8 to 40:60 Pentane:CH2Cl2) affording the 
title compound 9 (142 mg, 0.275 mmol, 92% yield, dr > 20:1 in the 
19F NMR) as a pale yellow oil. 
 
Rf 0.40 (Pentane/CH2Cl2 2/1). 
1H NMR (400 MHz, CDCl3) ???????? 7.47 (m, 1H, ArH), 7.41 ? 7.34 (m, 1H, ArH), 7.31 ? 7.21 
(m, 2H, ArH), 5.13 ? 4.84 (m, 1H, CHCF3), 4.30 ? 4.09 (m, 1H, CHN), 4.01 (d, J = 13.9 Hz, 1H, 
ArCH2), 3.95 (d, J = 13.9 Hz, 1H, ArCH2), 3.79 (s, 3H, CH3O), 3.35 ? 3.21 (m, 2H, CH2N), 3.12 
? 2.92 (m, 1H, CH2CC), 2.35 (dd, J = 16.4, 10.5 Hz, 1H, CH2CC), 1.07 ? 0.97 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) ? 155.7, 134.9, 134.1, 130.7, 129.7, 129.1, 127.1, 124.0 (q, 
J = 284.4 Hz), 104.0, 83.0, 78.0 (q, J = 34.0 Hz), 57.2, 56.4, 56.1, 53.4, 24.9, 18.6, 11.3. 
19F NMR (376 MHz, CDCl3) ? -76.6. 
IR ?max 2944 (w), 2864 (w), 2175 (w), 1717 (s), 1450 (m), 1362 (s), 1143 (s), 911 (s). 
HRMS calcd for C25H37ClF3N2O2Si+ [M+H]+ 517.2259; found 517.2259. 
 
 
Tert-butyl 3-(4-methoxybenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)imidazolidine-1-carboxylate (10) 
To an oven-dried 50 mL schlenk tube under nitrogen 
atmosphere was added degassed Toluene (4.50 mL), N-(4-
methoxybenzyl)prop-2-en-1-amine (0.532 g, 3.00 mmol) and 
1-((tert-butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate 
(2a) (0.849 g, 3.30 mmol, 1.1 equiv) and cesium carbonate 
(2.15 g, 6.60 mmol, 2.2 equiv). The resulting mixture was 
stirred for 30 min at 70 °C. Then 
(bromoethynyl)triisopropylsilane (3) (1.019 g, 3.90 mmol, 1.3 
equiv) was added followed by a premixed solution of Pd2(dba)3 (55.0 mg, 0.0600 mmol, 2 mol%) 
and tri(2-furyl)phosphine (0.0836 g, 0.360 mmol, 12 mol%) in toluene (4.50 mL). The resulting 
mixture was stirred for 20 h at 60 °C in an oil bath, then cooled down, filtered over Celite eluting 
with Et2O and concentrated under reduced pressure. The crude residue (> 20:1 dr by integration 
of the propargylic peaks in the crude 1H NMR)was purified by column chromatography on 
Biotage (SNAP cartridge KP-SIL 25 g, 88:12 Pentane:CH2Cl2 to 35:65 Pentane:CH2Cl2) to afford 
the title compound 10 (1.65 g, 2.98 mmol, 99 % yield, dr > 20:1 in the 1H NMR) as a yellow oil. 
 
Rf 0.20 (Pentane/CH2Cl2 1/1). 
1H NMR (400 MHz, CDCl3) ???????? 7.17 (m, 2H, ArH), 6.90 ? 6.82 (m, 2H, ArH), 5.09 ? 4.66 
(m, 1H, CHCF3), 4.10 ? 3.85 (m, 1H, CHN), 3.80 (s, 3H, OMe), 3.74 (s, 2H, ArCH2), 3.30 ? 3.18 
S29 
 
(m, 2H, CH2N), 2.98 (m, 1H, CH2CC), 2.26 (dd, J = 16.3, 10.5 Hz, 1H, CH2CC), 1.47 (s, 9H, 
Boc), 1.06 ? 0.98 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) ? 159.4, 154.3, 130.2, 129.3, 124.3 (q, J = 284.2 Hz), 114.1, 
104.5, 82.6, 81.6, 77.2 (q, J = 33.3 Hz, overlapping with chloroform signal), 59.4, 57.12, 56.0, 
55.4, 28.3, 25.1, 18.5, 11.3.  
IR ?max 2943 (s), 2870 (m), 2175 (w), 1711 (s), 1374 (s), 1251 (s), 1173 (s), 1036 (m), 881 (w). 
HRMS calcd for C29H45F3N2NaO3Si+ [M+Na]+ 577.3044; found 577.3044. 
 
 
 
Methyl 3-allyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)imidazolidine-1-
carboxylate (11) 
 
Following General Procedure A, the title compound was prepared from 
diallylamine (37.3 µl, 0.300 mmol), 2,2,2-trifluoro-1-
((methoxycarbonyl)amino)ethyl acetate (2aa) (71 mg, 0.33 mmol, 1.1 
equiv) and (bromoethynyl)triisopropylsilane (3) (86.0 mg, 0.330 mmol, 
1.1 equiv) at 60 °C. The crude oil was purified by column 
chromatography (SiO2 5:2 to 2:1 Pentane:CH2Cl2) affording the title 
compound 11 (124 mg, 0.287 mmol, 96 % yield, dr > 20:1 in the crude 
19F NMR) as a pale yellow oil. 
 
Rf 0.33 (Pentane/ CH2Cl2 5/2). 
1H NMR (400 MHz, CDCl3) ? 5.80 (ddt, J = 16.8, 10.3, 6.5 Hz, 1H, CHCH2), 5.24 ? 5.20 (m, 
1H, CHCH2), 5.20 ? 5.17 (m, 1H, CHCH2), 5.02 ? 4.78 (m, 1H, CHCF3), 4.20 ? 4.01 (m, 1H, 
CH2N), 3.75 (s, 3H, CH3O), 3.27 (app t, J = 7.5 Hz, 4H, CH2N and CH2CHCH2), 3.08 ? 2.91 (m, 
1H, CH2CC), 2.28 (dd, J = 16.4, 10.5 Hz, 1H, CH2CC), 1.09 ? 0.95 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) ? 155.8, 134.0, 124.1 (q, J = 284.2 Hz), 119.5, 104.1, 83.0, 
77.5 (m overlapping with chloroform signals), 59.1, 57.5, 56.3, 53.4, 25.1, 18.5, 11.3. 
19F NMR (376 MHz, CDCl3) ? -77.0. 
IR ?max 2953 (m), 2864 (w), 2174 (w), 1715 (m), 1448 (m), 1371 (m), 1177 (m), 1140 (m), 907 
(s). 
HRMS calcd. for C21H36F3N2O2Si+ [M+H]+ 433.2493; found 433.2499. 
 
 
Methyl 3-(furan-2-ylmethyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)imidazolidine-1-carboxylate (12) 
 
Following General Procedure A, the title compound was prepared from 
N-(furan-2-ylmethyl)prop-2-en-1-amine (41 mg, 0.30 mmol), 2,2,2-
trifluoro-1-((methoxycarbonyl)amino)ethyl acetate (2aa) (71 mg, 0.33 
mmol, 1.1 equiv) and (bromoethynyl)triisopropylsilane (3) (102 mg, 
0.390 mmol, 1.3 equiv). The crude oil was purified by column 
chromatography on Biotage (SNAP cartridge KP-SIL 25 g, 92:8 to 
40:60 Pentane:CH2Cl2) affording the title compound 12 (134 mg, 0.284 
mmol, 92% yield, dr > 20:1 in the crude 19F NMR) as a yellow oil. 
 
Rf 0.30 (Pentane/ CH2Cl2 2/1). 
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1H NMR (400 MHz, CDCl3) ???????? 7.31 (m, 1H, HetArH), 6.36 ? 6.28 (m, 1H, HetArH), 6.26 
? 6.20 (m, 1H, HetArH), 5.19 ? 4.97 (m, 1H, CHCF3), 3.93 ? 3.79 (m, 2H, HetArCH2), 3.71 (s, 
3H, CH3O), 3.73 ? 3.60 (m, 1H, CHN), 3.40 (dd, J = 12.5, 7.4 Hz, 1H, CH2N), 3.31 (dd, J = 12.5, 
8.7 Hz, 1H, CH2N), 3.00 ? 2.74 (m, 1H, CH2CC), 2.21 (dd, J = 16.4, 10.5 Hz, 1H, CH2CC), 1.15 
? 0.96 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) ? 155.6, 150.7, 143.1, 124.1 (q, J = 283.6 Hz), 110.6, 109.4, 
104.2, 82.9, 77.7 (q, J = 34.2 Hz, overlapping with chloroform signal), 57.7, 56.6, 53.2, 52.3, 
25.2, 18.8, 11.3. 
19F NMR (376 MHz, CDCl3) ? -77.5. 
IR ?max 2955 (s), 2869 (m), 2176 (w), 1722 (s), 1452 (m), 1367 (m), 1287 (w), 1180 (m), 1146 
(m), 1022 (w), 883 (w). 
HRMS calcd for C23H36F3N2O3Si+ [M+H]+ 473.2442; found 473.2447. 
 
 
Tert-butyl 3-ferrocenylmethyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)imidazolidine-1-carboxylate (13) 
 
Following General Procedure A, the title compound was prepared 
from ferrocenylmethyl allylamine (54) (76.5 mg, 0.300 mmol), 1-
((tert-butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) (85 
mg, 0.33 mmol, 1.3 equiv) and (bromoethynyl)triisopropylsilane 
(3) (102 mg, 0.390 mmol, 1.3 equiv). The crude oil (dr > 20:1 by 
integration of the propargylic peaks in the crude 1H NMR) was 
purified by column chromatography on Biotage (SNAP cartridge 
KP-SIL 25 g, 92:8 to 40:60 Pentane:CH2Cl2) affording the title 
compound 13 (168 mg, 0.266 mmol, 89% yield, dr > 20:1) as a 
dark oil. 
 
Rf 0.20 (Pentane/CH2Cl2 1/1). 
1H NMR (400 MHz, CDCl3) ??4.98 ? 4.73 (m, 1H, CHCF3), 4.19 ? 3.99 (m, 10H, ArH and 
CHN), 3.68 (d, J = 13.9 Hz, 1H, ArCH2), 3.60 (d, J = 13.9 Hz, 1H, ArCH2), 3.31 ? 3.11 (m, 2H, 
CH2N), 2.95 ? 2.75 (m, 1H, CH2CC), 2.12 (dd, J = 16.3, 10.4 Hz, 1H, CH2CC), 1.41 (s, 9H, 
Boc), 1.14 ? 0.82 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) ??????9, 124.3f (q, J = 284.6 Hz), 104.6, 82.4, 82.0, 81.3, 
77.5 (m overlapping with chloroform signal), 69.8, 69.3, 69.0, 68.8 (6C), 57.6-56.2 (3C), 28.3, 
25.1, 18.7, 11.3. 
IR ?max 2955 (m), 2869 (m), 2176 (w), 1710 (s), 1469 (w), 1373 (s), 1175 (s), 880 (w). 
HRMS calcd for C32H47F3FeN2NaO2Si+ [M+Na]+ 655.2600; found 655.2609. 
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Tert-butyl 2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)imidazolidine-1-
carboxylate (14) 
 
Following General Procedure A with a premixing time of 3 h at 35 °C, 
the title compound was prepared from allylamine (49) (22.5 µl, 0.300 
mmol), 1-((tert-butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) 
(85 mg, 0.33 mmol, 1.1 equiv) and (bromoethynyl)triisopropylsilane (3) 
(86.0 mg, 0.330 mmol, 1.1 equiv) at 70 °C. The crude oil was purified by 
column chromatography (SiO2 5:1 to 3:1 Pentane:Et2O) affording the title 
compound 14 (89.1 mg, 0.205 mmol, 68 % yield, dr > 20:1 in the crude 
1H NMR by integration of the propargylic signals) as a pale yellow oil. 
 
Rf 0.5 (Pentane:Et2O 2:1).  
1H NMR (400 MHz, CDCl3) ???????? 4.99 (m, 1H, CHCF3), 4.06 ? 3.84 (m, 1H, NCH), 3.61 (dd, 
J = 12.3, 7.5 Hz, 1H, CH2N), 3.23 ? 3.12 (m, 1H, CH2N), 3.13 ? 2.97 (m, 1H, CH2CC), 2.49 ? 
2.34 (m, 1H, NH), 2.25 (dd, J = 16.4, 10.5 Hz, 1H, CH2CC), 1.47 (s, 9H, Boc), 1.16 ? 0.90 (m, 
21H, TIPS). 
13C NMR (101 MHz, CDCl3) ? 154.1, 124.4 (q, J = 283.8 Hz), 104.3, 82.7, 81.7, 73.3 (q, J = 
33.7 Hz), 58.0, 52.3, 28.3, 25.4, 18.7, 11.3. 
IR ?max 3347 (w), 2944 (m), 2866 (w), 2175 (w), 1702 (s), 1464 (w), 1365 (s), 1282 (w), 1173 
(s), 1136 (s), 956 (w), 912 (m), 878 (m). 
HRMS (ESI) calcd for C21H37F3N2NaO2Si+ [M+Na]+ 457.2469; found 457.2458. 
 
 
Methyl 3-(4-methoxyphenyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)imidazolidine-1-carboxylate (15) 
 
Following General Procedure A with a premixing time of 1 h, the 
title compound was prepared from N-allyl-4-methoxyaniline (49.0 
mg, 0.300 mmol), 2,2,2-trifluoro-1-
((methoxycarbonyl)amino)ethyl acetate (2aa) (71 mg, 0.33 mmol, 
1.1 equiv) and (bromoethynyl)triisopropylsilane (3)  (102 mg, 
0.390 mmol, 1.3 equiv). The crude oil (dr > 20:1 in the  crude 19F 
NMR) was purified by column chromatography on Biotage 
(SNAP cartridge KP-SIL 25 g, 88:12 to 5:95 Pentane:CH2Cl2)  
affording the title compound 15 (121 mg, 0.243 mmol, 81 % yield, dr > 20:1 in the 19F NMR) as 
a deep yellow oil. 
 
Rf 0.40 (Pentane/CH2Cl2 1/1). 
1H NMR (400 MHz, CDCl3) ??6.90 ? 6.81 (m, 2H, ArH), 6.81 ? 6.71 (m, 2H, ArH), 5.83 ? 5.62 
(m, 1H, CHCF3), 4.38 ? 4.20 (m, 1H, CHN), 3.94 (app t, J = 9.4 Hz, 1H, CH2N), 3.80 (s, 3H, 
CH3O), 3.77 (s, 3H, CH3O), 3.71 ? 3.61 (m, 1H, CH2N), 3.13 ? 2.99 (m, 1H, CH2CC), 2.47 (dd, J 
= 16.6, 10.4 Hz, 1H, CH2CC), 1.15 ? 0.98 (m, 21H, TIPS). 
13C NMR (101 MHz, CDCl3) ???????, 154.1, 139.5, 124.5 (q, J = 288.7 Hz), 116.5, 114.9, 103.9, 
83.3, 74.0 (q, J = 33.9 Hz), 56.4, 55.7, 54.5, 53.6, 25.4, 18.7, 11.3. 
19F NMR (376 MHz, CDCl3) ? -75.8. 
IR ?max 2953 (s), 2869 (m), 2175 (w), 1722 (s), 1517 (s), 1451 (m), 1374 (m), 1253 (s), 1178 (s), 
1143 (s), 1038 (m), 911 (s). 
HRMS calcd for C25H38F3N2O3Si+ [M+H]+ 499.2598; found 499.2599. 
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Tert-butyl 3-benzyl-5-methyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)imidazolidine-1-carboxylate (16) 
Following General Procedure C with a premixing time of 1 h and 
Pd2dba3 (8.2 mg, 9.0 µmol, 3 mol%) and PhDavePhos (17.1 mg, 
0.0450 mmol, 15 mol%), the title compound was prepared from N-
benzyl-2-methylprop-2-en-1-amine (45) (48.4 mg, 0.300 mmol), 1-
((tert-butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) (85 
mg, 0.33 mmol, 1.1 equiv)  and (bromoethynyl)triisopropylsilane (3) 
(102 mg, 0.390 mmol, 1.3 equiv). The crude oil (>20:1 dr 
determined by integration in the crude 1H NMR) was purified by 
column chromatography on Biotage (SNAP cartridge KP-SIL 25 g, 
92:8 Pentane:CH2Cl2 to 40:60 Pentane: CH2Cl2) to afford the title compound 16 (137 mg, 0.254 
mmol, 85 % yield) as a yellow oil. 
 
Rf 0.30 (Pentane/CH2Cl2 2/1).  
1H NMR (400 MHz, Chloroform-d) ???????? 7.21 (m, 5H, ArH), 5.14 ? 4.98 (m, 1H, CHCF3), 
4.06 (d, J = 12.9 Hz, 1H, CH2Ph), 3.99 (d, J = 13.6 Hz, 1H, CH2Ph), 3.48 (d, J = 11.2 Hz, 1H, 
NCH2), 3.26 ? 3.02 (m, 1H, CCCH2), 2.96 (d, J = 11.3 Hz, 1H, NCH2), 2.56 (d, J = 16.5 Hz, 1H, 
CCCH2), 1.68 (s, 3H, Me), 1.51 (s, 9H, Boc), 1.13 ? 0.92 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) ? 152.8, 138.1, 128.7, 128.6, 127.7, 124.9 (d, J = 289.8 Hz),  
105.3, 82.7, 81.4, 77.5 (q, J = 31.9 Hz), 63.6, 63.0, 58.4, 31.2, 28.4, 23.7, 18.8, 11.6. 
IR ?max 3064 (w), 2939 (w), 2862 (w), 2174 (w), 1709 (s), 1464 (w), 1363 (s), 1275 (w), 1165 
(s), 1065 (m), 1029 (m), 883 (m). 
HRMS (ESI) calcd for C29H45F3N2NaO2Si+ [M+Na]+ 561.3095; found 561.3099. 
 
Stereochemistry assigned by ROESY. 
 
 
 
 
 
 
 
 
Tert-butyl 3-benzyl-5-((benzyloxy)methyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-
2-yn-1-yl)imidazolidine-1-carboxylate (17) 
Following General Procedure C with a premixing time of 3 h, the 
title compound was prepared from N-benzyl-2-
((benzyloxy)methyl)prop-2-en-1-amine (80.1 mg, 0.300 mmol)  (56) 
(125 mg, 0.300 mmol), 1-((tert-butoxycarbonyl)amino)-2,2,2-
trifluoroethyl acetate (2a) (85 mg, 0.33 mmol, 1.1 equiv)  and 
(bromoethynyl)triisopropylsilane (3) (102 mg, 0.390 mmol, 1.3 eq). 
The crude oil (>20:1 dr determined by integration in the crude 1H 
NMR) was purified by column chromatography on Biotage (SNAP 
cartridge KP-SIL 25 g, 97:3 Pentane:CH2Cl2 to 85:15 Pentane: Et2O) 
to afford the title compound 17 (135 mg, 0.209 mmol, 70 % yield) as a yellow oil. 
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Rf 0.50 (Pentane/Et2O 7/1).  
1H NMR (400 MHz, Chloroform-d) ? 7.37 ? 7.31 (m, 4H, ArH), 7.31 ? 7.19 (m, 6H, ArH), 5.06 
? 4.90 (m, 1H, CHCF3), 4.62 (d, J = 11.8 Hz, 1H, OCH2Ph), 4.51 (d, J = 11.8 Hz, 1H, OCH2Ph), 
4.29 ? 4.07 (m, 1H, OCH2), 4.06 ? 3.94 (m, 2H, NCH2Ph), 3.79 (d, J = 9.4 Hz, 1H, OCH2), 3.58 
(d, J = 12.0 Hz, 1H, NCH2), 3.20 (d, J = 12.0 Hz, 1H, NCH2), 3.07 (d, J = 16.9 Hz, 1H, CH2CC), 
2.60 (d, J = 16.9 Hz, 1H, CH2CC), 1.46 (s, 9H, Boc), 1.05 ? 0.92 (m, 21H, TIPS). 
13C NMR (101 MHz, Chloroform-d) ? 152.7, 139.1, 138.3, 128.8, 128.6, 128.4, 128.1, 127.9, 
127.3, 124.9 (d, J = 286.9 Hz), 104.1, 83.4, 81.3, 79.2 (q, J = 32.6 Hz), 73.9, 71.2, 65.9, 61.7, 
59.9, 28.4, 28.3, 18.7, 11.5. 
19F NMR (376 MHz, Chloroform-d) ? -76.8. 
IR ?max 2945 (m), 2866 (m), 2173 (w), 1710 (m), 1462 (w), 1364 (s), 1276 (w), 1166 (s), 1132 
(s), 911 (m). 
HRMS (ESI) calcd or C36H52F3N2O3Si+ [M+H]+ 645.3694; found 645.3691. 
 
 
 
Tert-butyl 3-benzyl-4-methyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-
yl)imidazolidine-1-carboxylate (18) 
 
Following General Procedure B with a premixing time of 1 h, the 
title compound was prepared from N-benzylbut-3-en-2-amine (46) 
(48.4 mg, 0.300 mmol), 1-((tert-butoxycarbonyl)amino)-2,2,2-
trifluoroethyl acetate (2a) (85 mg, 0.33 mmol, 1.1 equiv) and 
(bromoethynyl)triisopropylsilane (3) (102 mg, 0.390 mmol, 1.3 
equiv). The crude oil (2.2:1 dr determined by integration in the crude 
19F NMR) was purified by column chromatography on Biotage 
(SNAP cartridge KP-SIL 25 g, 95:5 to 60:40 Pentane:CH2Cl2) to 
afford the title compound 18 (132 mg, 0.245 mmol, 82 % yield, 2:1 
dr25 determined by integration in the 19F NMR) as a yellow oil. 
 
Rf 0.50 (Pentane/CH2Cl2 3/2). 
1H NMR (400 MHz, CDCl3) major diastereoisomer ? 7.39 ? 7.26 (m, 5H, ArH), 4.93 ? 4.80 (m, 
1H, CHCF3), 3.99 ? 3.86 (m, 2H, PhCH2), 3.82 ? 3.69 (m, 1H, CHNBoc), 3.56 ? 3.46 (m, 1H, 
CHNBn), 3.00 ? 2.87 (m, 1H, CH2CC), 2.57 (dd, J = 16.6, 10.1 Hz, 1H, CH2CC), 1.50 (s, 9H, 
Boc), 1.30 (d, J = 6.4 Hz, 3H, Me), 1.14 ? 0.89 (m, 21H, TIPS); minor diastereoisomer ? 7.39 ? 
7.26 (m, 5H, ArH), 4.93 ? 4.80 (m, 1H, CHCF3), 4.29 ? 4.20 (m, 1H, CHNBoc), 4.14 (d, J = 14.9 
Hz, 1H, PhCH2), 3.93 ? 3.87 (m, 1H, PhCH2), 3.31 ? 3.22 (m, 1H, CHNBn), 2.74 ? 2.66 (m, 1H, 
CH2CC), 2.64 ? 2.56 (m, 1H, CH2CC), 1.48 (s, 9H, Boc), 1.17 (d, J = 6.6 Hz, 3H, Me), 1.14 ? 
0.89 (m, 21H, TIPS). 
13C NMR (101 MHz, CDCl3) major diastereoisomer ???????????????????????????4, 127.5, 124.9 
(q, J = 289.0 Hz), 104.9, 83.1, 81.5, 74.2 (q, J = 32.6 Hz), 63.4, 60.5, 50.8, 28.4, 24.6, 18.7, 16.5, 
11.5; minor diastereoisomer ?????????????4, 128.8, 128.6, 127.6, 124.5 (q, J = 284.0 Hz), 106.0, 
82.5, 81.5, 75.7 (q, J = 33.2 Hz), 61.1, 60.5, 56.7, 28.3, 21.7, 18.7, 15.1, 11.6. 
19F NMR (376 MHz, CDCl3????-73.7, -76.7. 
IR ?max 2981 (s), 2904 (s), 2175 (w), 1711 (s), 1460 (m), 1376 (s), 1255 (m), 1160 (s), 1065 (s), 
915 (w). 
HRMS calcd for C29H46F3N2O2Si+ [M+H]+ 539.3275; found 539.3281.  
                                                 
25
 We assume that the two diastereoisomers arise from different configuration at the center bound to the methyl 
group. 
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Tert-butyl 3-benzyl-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)-4-
vinylimidazolidine-1-carboxylate (19) 
 
Following General Procedure B with a premixing time of 1 h, the title 
compound was prepared from N-benzylpenta-1,4-dien-3-amine (59) 
(52.0 mg, 0.300 mmol), 1-((tert-butoxycarbonyl)amino)-2,2,2-
trifluoroethyl acetate (2a) (85 mg, 0.33 mmol, 1.1 equiv) and 
(bromoethynyl)triisopropylsilane (3) (86 mg, 0.39 mmol, 1.1 equiv). 
The crude oil (87:13 dr determined by integration in the crude 19F 
NMR) was purified by column chromatography on Biotage (SNAP 
cartridge KP-SIL 25 g, 90:10 to 65:35 Pentane:CH2Cl2) to afford the title compound 19 (123 mg, 
0.223 mmol, 74 % yield, 93:7 dr determined by integration in the 19F NMR) as a yellow oil. 
 
Rf 0.5 (Pentane/Et2O 20/1). 
1H NMR (400 MHz, Acetonitrile-d3) ? 7.37 ? 7.23 (m, 5H, ArH), 5.73 (ddd, J = 17.0, 10.2, 9.0 
Hz, 1H, CH=C), 5.31 (dd, J = 10.2, 1.5 Hz, 1H, CH2=C), 5.14 (dd, J = 17.0, 1.5 Hz, 1H, CH2=C), 
4.98 (q, J = 5.3 Hz, 1H, CHCF3), 4.00 (d, J = 14.3 Hz, 1H, PhCH2), 3.94 ? 3.84 (m, 1H, 
CHNBoc), 3.88 (d, J = 14.3 Hz, 1H, PhCH2), 3.74 (dd, J = 9.2, 3.4 Hz, 1H, CHN), 2.72 (dd, J = 
16.9, 9.0 Hz, 1H, CH2CC), 2.63 (dd, J = 17.0, 4.7 Hz, 1H, CH2CC), 1.46 (s, 9H, Boc), 1.08 ? 
0.92 (m, 21H, TIPS). 
13C NMR (101 MHz, CD3CN) ? 155.0, 139.1, 135.6, 129.4, 129.18, 128.2, 125.7 (q, J = 287.1 
Hz), 121.3, 105.7, 83.6, 82.4, 74.7, 67.7, 63.0, 51.6, 28.3, 24.5, 19.0, 12.0. 
19F NMR (376 MHz, CDCl3) ? -73.8. 
IR ?max 2942 (m), 2865 (m), 2176 (w), 1716 (s), 1463 (w), 1370 (s), 1258 (w), 1161 (s), 1065 
(w), 1018 (w), 931 (w), 880 (w), 847 (w). 
HRMS calcd for C30H46F3N2O2Si+ [M+H]+ 551.3275; found 551.3256. 
 
Stereochemistry assigned by 1D NOESY. 
 
 
 
 
 
 
Tert-butyl 3-(trifluoromethyl)-1-(3-(triisopropylsilyl)prop-2-yn-1-yl)tetrahydro-1H-
pyrrolo[1,2-c]imidazole-2(3H)-carboxylate (20) 
 
To an oven-dried 5 mL microwave tube under nitrogen atmosphere was 
added 1-((tert-butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) 
(85 mg, 0.33 mmol, 1.1 equiv), cesium carbonate (225 mg, 0.690 mmol) 
and 2-vinylpyrrolidine hydrochloride (61) (40.1 mg, 0.300 mmol). The 
tube was sealed, evacuated and backfilled with nitrogen (this was 
repeated for a total of 3 times). Then dry toluene was added (0.45 mL) 
and the resulting mixture was stirred for 4 h at 50 °C. Then the mixture 
was filtered to an oven-dried 5 mL microwave tube. The volatiles were 
removed under reduced pressure and cesium carbonate (127 mg, 0.390 mmol) was added. The 
tube was sealed evacuated and backfilled with nitrogen (this was repeated for a total of 3 times), 
then a premixed solution of Pd2dba3 (11 mg, 12 µmol) and Tri(2-furyl)phosphine (17 mg, 0.072 
mmol) in toluene (0.90 mL) was added followed by (bromoethynyl)triisopropylsilane (3) (102 
mg, 0.390 mmol) The resulting mixture was stirred for 20 h at 75 °C in an oil bath, then cooled 
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down, filtered over Celite eluting with Et2O and concentrated under reduced pressure. The crude 
oil (92.5:7.5 dr determined by integration in the crude 19F NMR) was purified by column 
chromatography on Biotage (SNAP cartridge KP-SIL 25 g, 98:2 to 80:20 Pentane:Et2O) to afford 
the title compound 20 (112 mg, 0.236 mmol, 79 % yield, dr > 98:2 determined by integration in 
the 19F NMR) as a pale yellow oil. 
 
Rf 0.70 (Pentane/Et2O 6/1). 
1H NMR (400 MHz, CDCl3) ? 5.10 ? 4.77 (m, 1H, CHCF3), 3.81 ? 3.68 (m, 1H, CHN), 3.68 ? 
3.44 (m, 1H, CHNBoc), 3.32 ? 3.21 (m, 1H, CH2N), 3.17 ? 2.92 (m, 1H, CH2CC), 2.63 (app q, J 
= 8.2 Hz, 1H, CH2N), 2.29 (dd, J = 13.6, 7.8 Hz, 1H, CH2CC), 2.25 ? 2.17 (m, 1H, NCHCH2), 
1.99 ? 1.91 (m, 1H, NCHCH2), 1.91 ? 1.81 (m, 2H, NCH2CH2), 1.47 (s, 9H, Boc), 1.11 ? 0.95 
(m, 21H, TIPS). 
13C NMR (101 MHz, CDCl3) ?????????124.0 (q, J = 283.1 Hz), 104.0, 82.9, 81.6, 78.7 (q, J = 
33.8 Hz), 69.5, 63.0, 55.3, 31.9, 28.3, 25.2, 25.0, 18.7, 11.3. 
19F NMR (376 MHz, CDCl3????-78.4. 
IR ?max 2943 (w), 2867 (w), 2174 (w), 1710 (m), 1464 (w), 1369 (s), 1288 (m), 1161 (s), 879 (w). 
HRMS calcd for. C24H42F3N2O2Si+ [M+H]+ 475.2962; found 475.2962. 
 
 
Tert-butyl 3-(trifluoromethyl)-1-(3-(triisopropylsilyl)prop-2-yn-1-yl)hexahydroimidazo[1,5-
a]pyridine-2(3H)-carboxylate (21) 
 
To an oven-dried 5 mL microwave tube under nitrogen atmosphere was 
added 1-((tert-butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) 
(85 mg, 0.33 mmol, 1.1 equiv), cesium carbonate (225 mg, 0.690 mmol) 
and 2-vinylpiperidine 2,2,2-trifluoroacetate (63) (67.6 mg, 0.300 mmol). 
The tube was sealed, evacuated and backfilled with nitrogen (this was 
repeated for a total of 3 times). Then dry toluene was added (0.45 mL) 
and the resulting mixture was stirred for 4 h at 50 °C. Then the mixture 
was filtered to an oven-dried 5 mL microwave tube. The volatiles were 
removed under reduced pressure and cesium carbonate (127 mg, 0.390 
mmol) was added. The tube was sealed, evacuated and backfilled with nitrogen (this was 
repeated for a total of 3 times), then a premixed solution of Pd2dba3 (11 mg, 12 µmol) and Tri(2-
furyl)phosphine (17 mg, 0.072 mmol) in toluene (0.90 mL) was added followed by 
(bromoethynyl)triisopropylsilane (3) (102 mg, 0.390 mmol) The resulting mixture was stirred for 
20 h at 75 °C in an oil bath, then cooled down, filtered over Celite eluting with Et2O and 
concentrated under reduced pressure. The crude oil (90:10 dr determined by integration in the 
crude 1H NMR) was purified by column chromatography on Biotage (SNAP cartridge KP-SIL 25 
g, 95:5 to 80:20 Pentane:Et2O) to afford the title compound 21 (113 mg, 0.231 mmol, 77 % yield, 
dr > 98:2 determined by integration in the 1H NMR) as a yellow oil. 
Rf 0.75 (Pentane/Et2O 6/1). 
1H NMR (400 MHz, CDCl3) ? 4.46 ? 4.26 (m, 1H, CHCF3), 4.26 ? 4.04 (m, 1H, CHNBoc), 3.34 
? 3.20 (m, 1H, NCH2), 2.64 (dd, J = 17.0, 10.1 Hz, 1H, CH2CC), 2.56 ? 2.43 (overlapping m, 2H, 
CH2CC and CHN), 2.32 (td, J = 11.0, 3.5 Hz, 1H, NCH2), 1.85 (app t, J = 16.3 Hz, 2H), 1.66 ? 
1.45 (m, 3H), 1.47 (s, 9H, Boc), 1.34 ? 1.14 (m, 1H), 1.11 ? 0.96 (m, 21H, TIPS) 
13C NMR (101 MHz, CDCl3) ? 153.6, 124.3 (q, J = 283.9 Hz), 105.6, 82.0, 81.5, 76.5 ? 74.8 (m), 
65.2, 61.1 ? 58.8 (m), 51.8, 28.3, 26.8, 25.3, 23.8, 21.7, 18.7, 11.4. 
IR ?max 2953 (s), 2865 (s), 2177 (w), 1716 (s), 1464 (w), 1371 (s), 1277 (w), 1166 (s), 1041 (w), 
1003 (w), 932 (w), 881 (m), 861 (m). 
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HRMS calcd for C25H44F3N2O2Si+ [M+H]+ 489.3119; found 489.3125.  
 
 
Tert-butyl 3-(trifluoromethyl)-1-(3-(triisopropylsilyl)prop-2-yn-1-yl)tetrahydro-1H-
pyrrolo[1,2-c]imidazole-2(3H)-carboxylate (22) 
 
Following General Procedure B with a premixing time of 4 h at 70 °C, 
the title compound was prepared from cis-1,3-divinylisoindoline (65) 
(51.4 mg, 0.300 mmol), 1-((tert-butoxycarbonyl)amino)-2,2,2-
trifluoroethyl acetate (2a) (85 mg, 0.33 mmol, 1.1 equiv)  and 
(bromoethynyl)triisopropylsilane (3) (102 mg, 0.390 mmol, 1.3 equiv). 
The crude oil (dr > 98:2 determined by integration in the crude 19F 
NMR) was purified by column chromatography on Biotage (SNAP 
cartridge KP-SIL 25 g, 90:10 to 40:60 Pentane:CH2Cl2) to afford the 
title compound 22 (92 mg, 0.168 mmol, 56 % yield, dr > 98:2 
determined by integration in the 19F NMR) as a yellow oil. 
 
Rf 0.40 (Pentane/CH2Cl2 3/2). 
1H NMR (400 MHz, Benzene-d6?? ?? ????? ?app d, J = 7.5 Hz, 1H, ArH), 7.23 ? 7.13 (m 
overlapping with benzene-d6 signal, 1H, ArH), 7.08 (app t, J = 7.6 Hz, 1H, ArH), 6.87 (d, J = 7.6 
Hz, 1H, ArH), 5.65 ? 5.32 (m, 1H, CHCF3), 5.31 ? 5.14 (m, 1H, CHCH2), 5.10 (d, J = 7.2 Hz, 
1H, CHN), 4.98 (app d, J = 16.9 Hz, 1H, CHCH2), 4.91 (app d, J = 9.8 Hz, 1H, CHCH2), 4.79 (d, 
J = 9.8 Hz, 1H, CHAr), 3.88 ? 3.75 (m, 1H, CHNBoc), 3.27 ( app d, J = 16.8 Hz, 1H, CCCH2), 
2.69 (dd, J = 16.8, 9.9 Hz, 1H, CCCH2), 1.30 (s, 9H, Boc), 1.24 ? 1.09 (m, 21H, TIPS). 
13C NMR (101 MHz, C6D6????????2, 141.2, 139.9, 137.7, 128.5, 127.9, 125.4 (q, J = 282.9 Hz), 
124.8, 123.9, 119.9, 105.9, 84.1, 81.1, 75.7, 74.4 (q, J = 34.6 Hz), 72.5, 64.0, 28.2, 25.9, 19.0, 
11.9. 
19F NMR (376 MHz, CDCl3????-77.7. 
IR ?max 2944 (m), 2868 (w), 2172 (w), 1711 (m), 1468 (w), 1363 (s), 1286 (m), 1153 (s), 1004 
(w), 932 (w), 877 (w). 
HRMS calcd for C30H44F3N2O2Si+ [M+H]+ 549.3119; found 549.3130. 
 
Stereochemistry assigned by 1D NOESY. 
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Tert-butyl 3-benzyl-2-(trifluoromethyl)-5-(4-((triisopropylsilyl)oxy)dec-2-yn-1-
yl)imidazolidine-1-carboxylate (23) 
Following General Procedure A, using Pd2dba3 (11.0 mg, 12.0 µmol) 
and DPEPhos (19.4 mg, 0.036 mmol), the title compound was 
prepared from N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 
1-((tert-butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) (85 
mg, 0.33 mmol, 1.1 equiv) and ((1-bromonon-1-yn-3-
yl)oxy)triisopropylsilane (78) (0.146 g, 0.390 mmol, 1.3 equiv). The 
crude oil (1:1 dr at the propargylic center determined by integration in 
the crude 1H NMR) was purified by column chromatography on 
Biotage (SNAP cartridge KP-SIL 25 g, 85:15 to 40:60 
Pentane:CH2Cl2) to afford the title compound 23 (0.170 g, 0.266 mmol, 89 % yield) as a yellow 
oil. 
 
Rf 0.28 (Pentane:CH2Cl2 2:1).  
1H NMR (400 MHz, CDCl3) ? 7.37 ? 7.27 (m, 5H, ArH), 5.00 ? 4.73 (m, 1H, CHCF3), 4.37 (td, 
J = 6.4, 1.7 Hz, 1H, CHOTIPS), 4.09 ? 3.88 (m, 1H, CHN), 3.88 ? 3.76 (m, 2H, CH2Ph), 3.26 ? 
3.13 (m, 2H, CH2N), 3.04 ? 2.78 (m, 1H, CH2CC), 2.25 (app ddt, J = 16.3, 10.6, 1.7 Hz, 1H, 
CH2CC), 1.64 ? 1.57 (m, 2H), 1.52 ? 1.44 (m, 10H, Boc and CH2), 1.44 ? 1.33 (m, 1H, CH2), 
1.32 ? 1.22 (m, 6H, CH2CH2CH2), 1.12 ? 0.97 (m, 21H, TIPS), 0.88 (t, J = 6.8 Hz, 3H, CH3). 
13C NMR (101 MHz, CDCl3) ? 154.2, 137.4, 128.8, 128.7, 128.0, 124.3 (q, J = 284.7 Hz), 84.1, 
81.6, 80.0, 77.3 (m overlapping with chloroform signal), 63.3, 60.0, 57.1, 55.9, 39.2, 31.9, 29.2, 
28.3, 25.1, 24.0, 22.7, 18.2, 18.1 (diastereoisomer), 14.2, 12.4. 
IR ?max 2938 (w), 2853 (w), 1714 (s), 1465 (w), 1364 (s), 1287 (w), 1172 (s), 882 (w). 
HRMS (ESI) calcd for C35H57F3N2NaO3Si+ [M+Na]+ 661.3983; found 661.3980. 
 
 
Tert-butyl 3-benzyl-5-(4-methyl-4-((triisopropylsilyl)oxy)pent-2-yn-1-yl)-2-
(trifluoromethyl)imidazolidine-1-carboxylate (24) 
 
Following General Procedure A, using Pd2dba3 (11.0 mg, 12.0 µmol) 
and DPEPhos (19.4 mg, 0.036 mmol), the title compound was 
prepared from N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 
mmol), 1-((tert-butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate 
(2a) (85 mg, 0.33 mmol, 1.1 equiv)  and ((4-bromo-2-methylbut-3-
yn-2-yl)oxy)triisopropylsilane (73) (125 mg, 0.390 mmol, 1.3 equiv). 
The crude oil (>20:1 dr determined by integration in the crude 1H 
NMR) was purified by column chromatography on Biotage (SNAP 
cartridge KP-SIL 25 g, 90:10 to 60:40 Pentane:CH2Cl2) to give the 
title compound 24 (133 mg, 0.228 mmol, 76 % yield) as a yellow oil. 
 
Rf 0.50 (Pentane/CH2Cl2 1/1). 
1H NMR (400 MHz, CDCl3) ???????? 7.27 (m, 5H, ArH), 5.05 ? 4.71 (m, 1H, CHCF3), 3.98 (s, 
1H, CHN), 3.87 ? 3.76 (m, 2H, CH2Ph), 3.23 ? 3.12 (m, 2H, CH2N), 2.97 ? 2.77 (m, 1H, 
CH2CC), 2.24 (dd, J = 16.2, 10.3 Hz, 1H, CH2CC), 1.47 (s, 9H, Boc), 1.43 (s, 3H, Me), 1.43 (s, 
3H, Me), 1.13 ? 0.98 (m, 21H, TIPS). 
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13C NMR (101 MHz, CDCl3) ? 154.2, 137.4, 128.9, 128.8, 128.0, 124.28 (q, J = 283.9 Hz), 87.7, 
81.6, 78.1, 77.2 (m overlapping with chloroform signal), 66.3, 60.0, 57.1, 55.7, 33.5, 28.4, 24.0, 
18.4, 13.1. 
IR ?max 2940 (m), 2866 (w), 2239 (w), 1715 (s), 1464 (w), 1366 (s), 1246 (m), 1165 (s), 1062 
(w), 881 (w). 
HRMS calcd for for C35H57F3N2NaO3Si+ [M+Na]+ 661.3983; found 661.3980. 
 
 
Tert-butyl 3-benzyl-5-(4-(benzyloxy)-4-methylpent-2-yn-1-yl)-2-
(trifluoromethyl)imidazolidine-1-carboxylate (25) 
Following General Procedure A, using Pd2dba3 (11.0 mg, 12.0 
µmol) and DPEPhos (19.4 mg, 0.036 mmol), the title compound was 
prepared from N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 
mmol), 1-((tert-butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate 
(2a) (85 mg, 0.33 mmol, 1.1 equiv) and ((1-bromonon-1-yn-3-
yl)oxy)triisopropylsilane (75) (0.146 g, 0.390 mmol, 1.3 equiv). The 
crude oil was purified by column chromatography on Biotage 
(SNAP cartridge KP-SIL 25 g, 80:20 to 0:10 Pentane:CH2Cl2) to 
afford the title compound (95.4 mg, 0.184 mmol, 62 % yield) as a 
yellow oil. 
 
Rf 0.30 (Pentane:Et2O 4:1).  
1H NMR (400 MHz, CDCl3) ? 7.36 ? 7.28 (m, 9H, ArH), 7.28 ? 7.24 (m, 1H, ArH), 4.96 ? 4.70 
(m, 1H, CHCF3), 4.54 (s, 2H, CH2O), 4.13 ? 3.88 (m, 1H, CHN), 3.84 ? 3.74 (m, 2H, NCH2Ph), 
3.27 ? 3.11 (m, 2H, CH2N), 2.98 ? 2.81 (m, 1H, CH2CC), 2.34 (dd, J = 16.3, 10.0 Hz, 1H, 
CH2CC), 1.47 (app s, 15H, CH3 and Boc). 
13C NMR (101 MHz, CDCl3) ? 154.2, 139.3, 137.3, 128.8, 128.7, 128.4, 128.0, 127.7, 127.4, 
124.2 (q, J = 284.5 Hz), 84.4, 81.7, 80.4, 77.2 (m overlapping with chloroform signal), 70.8, 
66.5, 59.9, 56.9, 55.8, 29.2, 28.3, 23.7. 
IR ?max 2986 (s), 2906 (m), 2177 (w), 1706 (w), 1385 (m), 1246 (w), 1061 (s), 906 (w). 
HRMS (ESI) calcd for C29H36F3N2O3+ [M+H]+ 517.2673; found 517.2675. 
 
 
Methyl 3-benzyl-5-(4-((tert-butyldimethylsilyl)oxy)-5,5,5-trifluoro-4-phenylpent-2-yn-1-yl)-
2-(trifluoromethyl)imidazolidine-1-carboxylate (26) 
Following General Procedure A, using Pd2dba3 (11.0 mg, 12.0 µmol) 
and DPEPhos (19.4 mg, 0.036 mmol), the title compound was prepared 
from N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 2,2,2-
trifluoro-1-((methoxycarbonyl)amino)ethyl acetate (2a) (71 mg, 0.33 
mmol, 1.1 equiv)  and ((4-bromo-1,1,1-trifluoro-2-phenylbut-3-yn-2-
yl)oxy)(tert-butyl)dimethylsilane (81) (153 mg, 0.390 mmol, 1.3 
equiv). The crude oil (1:1 dr at the propargylic center, determined by 
integration in the crude 1H NMR) was purified by column 
chromatography on Biotage (SNAP cartridge KP-SIL 25 g, 97:3 to 
85:15 Pentane:Et2O) to afford the title compound 26 (0.177 g, 0.288 
mmol, 96 % yield) as a yellow oil. 
 
Rf 0.25 (Pentane:Et2O 8:1).  
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1H NMR (400 MHz, CDCl3) ? 7.71 ? 7.62 (m, 2H, ArH), 7.41 ? 7.27 (m, 8H, ArH), 5.10 ? 4.86 
(m, 1H, CHCF3), 4.24 ? 4.04 (m, 1H, CHN), 3.98 ? 3.86 (m, 1H, CH2Ph), 3.81 (d, J = 13.1 Hz, 
1H, CH2Ph), 3.77 (s, 3H, OMe for the first diastereoisomer), 3.75 (s, 3H, OMe for the second 
diastereoisomer) 3.33 ? 3.18 (m, 2H, CH2N), 3.18 ? 2.98 (m, 1H, CH2CC), 2.42 (dd, J = 16.5, 
10.1 Hz, 1H, CH2CC), 0.96 (s, 9H, t-Bu), 0.20 (app d, J = 3.5 Hz, 3H, Me), -0.03 (app d, J = 2.2 
Hz, 3H, Me). 
13C NMR (101 MHz, CDCl3) ? 155.6, 137.5, 136.9, 129.2, 128.9, 128.8, 128.1, 128.0, 127.5, 
124.1 (q, J = 284.5 Hz), 123.4 (q, J = 286.3 Hz), 86.2, 78.7 (first diastereoisomer), 78.7 (second 
diastereoisomer), 77.3 (m overlapping with chloroform signal), 74.4 (q, J = 32.4 Hz), 59.9, 57.1, 
55.7, 53.5, 25.8, 24.0, 18.5, -3.2, -3.3. 
IR ?max 2956 (w), 2854 (w), 2248 (w), 1720 (m), 1447 (m), 1360 (w), 1264 (w), 1172 (s), 1146 
(m), 1099 (m), 915 (w), 864 (m). 
HRMS calcd for C30H37F6N2O3Si+ [M+H]+ 615.2472; found 615.2494. 
 
 
Tert-butyl 3-benzyl-5-(2-fluorobenzyl)-2-(trifluoromethyl)imidazolidine-1-carboxylate (27) 
 
Following General Procedure D, the title compound was prepared 
from N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 1-
((tert-butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) (85 
mg, 0.33 mmol, 1.1 equiv) and 1-bromo-2-fluorobenzene (47) (79 
mg, 0.45 mmol, 1.5 equiv) at 70 °C. The crude oil (dr > 20:1 
determined by integration in the 1H NMR of the crude) was purified 
by column chromatography on Biotage (SNAP cartridge KP-SIL 25 
g, 85:15 to 40:60 Pentane:CH2Cl2) to afford the title compound 27 
(108 mg, 0.246 mmol, 82 % yield) as a yellow oil. 
 
Rf 0.40 (Pentane:CH2Cl2 5:7).  
1H NMR (400 MHz, CDCl3) ???????? 7.26 (m, 5H, ArH), 7.23 ? 7.14 (m, 2H, ArH), 7.08 ? 6.97 
(m, 2H, ArH), 5.08 ? 4.79 (m, 1H, CHCF3), 4.32 ? 4.17 (m, 1H, CHN), 3.88 (d, J = 13.4 Hz, 1H 
PhCH2), 3.74 (d, J = 13.2 Hz, 1H, PhCH2), 3.40 ? 3.26 (m, 1H, NCH2), 3.13 (dd, J = 11.6, 6.9 
Hz, 1H, ArCH2), 2.88 (dd, J = 11.6, 7.4 Hz, 1H, ArCH2), 2.84 ? 2.71 (m, 1H, NCH2), 1.48 (s, 9H, 
Boc). 
13C NMR (101 MHz, CDCl3) ? 161.4 (d, J = 245.4 Hz), 154.6, 137.6, 131.8 (d, J = 4.9 Hz), 
128.7, 128.6, 128.4 (d, J = 8.0 Hz), 127.8, 125.0 (d, J = 16.2 Hz), 124.41 (q, J = 284.4 Hz), 124.2 
(d, J = 3.6 Hz), 115.4 (d, J = 22.1 Hz), 81.4, 77.2 (q, J = 33.1 Hz), 59.7, 57.0, 56.7, 34.0, 28.3. 
IR ?max 3039 (w), 2824 (w), 1704 (s), 1490 (w), 1364 (s), 1286 (m), 1237 (m), 1155 (s), 907 (s). 
HRMS (ESI) calcd for C23H27F4N2O2+ [M+H]+ 439.2003; found 439.2004. 
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Tert-butyl 3-benzyl-5-(2-(trifluoromethoxy)benzyl)-2-(trifluoromethyl)imidazolidine-1-
carboxylate (28) 
 
Following General Procedure D, the title compound was prepared 
from N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 1-((tert-
butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) (85 mg, 
0.330 mmol, 1.1 equiv) and 1-bromo-2-(trifluoromethoxy)benzene 
(67 µl, 0.45 mmol, 1.5 eq) at 70 °C. The crude oil (dr > 20:1 
determined by integration in the crude 19F NMR of the crude) was 
purified by column chromatography on Biotage (SNAP cartridge KP-
SIL 25 g, 85:15 to 50:50 Pentane:CH2Cl2) to afford the title 
compound 28 (122 mg, 0.242 mmol, 81 % yield) as a yellow oil. 
 
Rf 0.45 (Pentane:CH2Cl2 5:7).  
1H NMR (400 MHz, CDCl3) ???????? 7.12 (m, 9H, ArH), 4.98 ? 4.84 (m, 1H, CHCF3), 4.30 ? 
4.16 (m, 1H, CHN), 3.87 (d, J = 13.0 Hz, 1H, CH2Ph), 3.71 (d, J = 13.0 Hz, 1H, CH2Ph), 3.31 ? 
3.20 (m, 1H, CH2Ar), 3.11 ? 3.01 (m, 1H, CH2N), 2.92 ? 2.80 (m, 2H, CH2Ar and CH2N), 1.43 
(s, 9H, Boc). 
13C NMR (101 MHz, CDCl3) ? 154.3, 147.8, 137.3, 131.9, 130.5, 128.6, 128.5, 127.9, 127.7, 
126.7, 124.3 (q, J = 284.7 Hz), 120.5 (q, J = 257.5 Hz), 120.2, 81.3, 77.2 (m overlapping with 
chloroform signals), 59.7, 56.9, 56.5, 34.2, 28.1. 
19F NMR (376 MHz, Chloroform-d????-56.89, -76.21. 
IR ?max 3067 (w), 2821 (w), 1710 (m), 1490 (w), 1455 (w), 1367 (m), 1258 (s), 1170 (s), 917 (w). 
HRMS (ESI) calcd for C24H27F6N2O3+ [M+H]+ 505.1920; found 505.1924. 
 
 
Tert-butyl 3-benzyl-5-(2-bromobenzyl)-2-(trifluoromethyl)imidazolidine-1-carboxylate (29) 
 
Following General Procedure D, the title compound was prepared from 
N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 1-((tert-
butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) (85 mg, 0.33 
mmol, 1.1 equiv) and 1,2-dibromobenzene (54 µL, 0.45 mmol, 1.5 eq) 
at 70 °C. The crude oil (dr > 20:1 determined by integration in the 19F 
NMR of the crude) was purified by column chromatography on Biotage 
(SNAP cartridge KP-SIL 25 g, 85:15 to 50:50 Pentane:CH2Cl2) to 
afford the title compound 29 (95.0 mg, 0.190 mmol, 63 % yield) as a 
yellow oil. 
 
Rf 0.40 (Pentane:CH2Cl2 5:7).  
1H NMR (400 MHz, CDCl3) ???????????J = 7.9 Hz, 1H, ArH), 7.38 ? 7.22 (m, 5H, ArH), 7.22 ? 
7.16 (m, 2H, ArH), 7.12 ? 7.03 (m, 1H, ArH), 5.06 ? 4.79 (m, 1H, CHCF3), 4.45 ? 4.29 (m, 1H, 
CHN), 4.02 ? 3.83 (m, 1H, CH2Ph), 3.77 ? 3.66 (m, 1H, CH2Ph), 3.44 ? 3.22 (m, 1H, CH2Ar), 
3.22 ? 3.05 (m, 1H, CH2N), 3.00 ? 2.88 (m, 1H, CH2Ar), 2.88 ? 2.75 (m, 1H, CH2N), 1.40 (s, 9H, 
Boc). 
13C NMR (101 MHz, CDCl3) ? 154.3, 137.6, 137.4, 132.7, 131.7, 128.6, 128.5, 128.1, 127.6, 
127.4, 124.7, 124.3 (q, J = 284.7 Hz), 81.2, 77.2 (m overlapping with chloroform signals), 59.6, 
56.4, 56.2, 39.9, 28.2. 
19F NMR (376 MHz, Chloroform-d????-75.9. 
IR ?max 3065 (w), 2823 (w), 1709 (s), 1452 (w), 1365 (s), 1286 (m), 1170 (s), 914 (m). 
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HRMS (ESI) calcd for C23H2779BrF3N2O2+ [M+H]+ 499.1202; found 499.1193. 
 
 
Methyl 3-benzyl-5-(2-bromo-4-formylbenzyl)-2-(trifluoromethyl)imidazolidine-1-
carboxylate) (30) 
 
Following General Procedure D, the title compound was prepared from N-
benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 2,2,2-trifluoro-1-
((methoxycarbonyl)amino)ethyl acetate (2aa) (71 mg, 0.33 mmol, 1.1 
equiv) and 3,4-dibromobenzaldehyde (158 mg, 0.600 mmol, 2.0 eq) at 70 
°C. The crude oil (dr > 20:1 determined by integration in the crude 1H 
NMR of the crude) was purified by column chromatography on Biotage 
(SNAP cartridge KP-SIL 25 g, 70:30 to 10:90 Pentane:Et2O) to afford the 
title compound 30 (137 mg, 0.282 mmol, 94% yield) as a pale yellow oil. 
 
Rf 0.30 (Pentane:Et2O 1:1).  
1H NMR (400 MHz, CDCl3) ?????????????, CHO), 8.08 ? 7.99 (m, 1H, ArH), 7.74 ? 7.66 (m, 1H, 
ArH), 7.37 ? 7.27 (m, 6H, ArH), 5.04 ? 4.89 (m, 1H, CHCF3), 4.46 ? 4.34 (m, 1H, CHN), 3.91 
(d, J = 13.3 Hz, 1H, CH2Ph), 3.73 (d, J = 13.3 Hz, 1H, CH2Ph), 3.64 (s, 3H, Me), 3.52 ? 3.30 (m, 
1H, CH2Ar), 3.15 (dd, J = 11.6, 6.7 Hz, 1H, CH2N), 3.01 (dd, J = 13.2, 8.0 Hz, 1H, CH2Ar), 2.92 
(dd, J = 11.6, 7.5 Hz, 1H, CH2N). 
13C NMR (101 MHz, CDCl3) ? 190.5, 155.9, 144.5, 137.2, 136.5, 133.9, 132.2, 128.7 (2C), 
128.6, 128.0, 125.7, 124.2 (d, J = 284.0 Hz), 77.2 (m overlapping with chloroform signal), 59.7, 
56.5 (2C), 53.3, 40.5. 
IR ?max 2973 (m), 1713 (s), 1598 (w), 1453 (m), 1369 (s), 1181 (s), 1139 (s), 1068 (m). 
HRMS (ESI) calcd for C21H2079BrF3N2NaO3+ [M+Na]+ 507.0502; found 507.0500. 
 
 
Tert-butyl 3-benzyl-5-(4-(methoxycarbonyl)benzyl)-2-(trifluoromethyl)imidazolidine-1-
carboxylate (31) 
 Following General Procedure D, the title compound was prepared from 
N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 1-((tert-
butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) (85 mg, 0.330 
mmol, 1.1 equiv) and methyl 4-bromobenzoate (97 mg, 0.45 mmol, 1.5 
equiv) at 70 °C. The crude oil (dr > 20 determined by integration in the 
crude 1H NMR) was purified by column chromatography on Biotage 
(SNAP cartridge KP-SIL 25 g, 95:15 to 75:25 Pentane:Et2O) affording 
the title compound 31 (107 mg, 0.224 mmol, 75 % yield) as a yellow 
oil. 
 
Rf 0.35 (Pentane:Et2O 4:1).  
1H NMR (400 MHz, CDCl3????7.96 ? 7.91 (m, 2H, ArH), 7.35 ? 7.19 (m, 7H, ArH), 5.07 ? 4.76 
(m, 1H, CHCF3), 4.23 ? 4.04 (m, 1H, CHN), 3.89 (s, 3H, Me), 3.88 ? 3.78 (m, 1H, CH2Ph), 3.72 
(d, J = 13.2 Hz, 1H, CH2Ph), 3.51 ? 3.31 (m, 1H, CH2Ar), 3.07 (ddd, J = 11.6, 7.1, 1.4 Hz, 1H, 
CH2N), 2.88 ? 2.80 (m, 1H, CH2N), 2.67 (dd, J = 13.0, 9.6 Hz, 1H, CH2Ar), 1.48 (s, 9H, Boc). 
13C NMR (101 MHz, CDCl3) ? 167.0, 154.3, 143.5, 137.4, 130.0, 129.3, 128.7 (2C), 128.6, 
127.9, 124.4 (q, J = 284.8 Hz) 81.6, 77.1 (q, J = 33.1 Hz), 59.7, 58.0, 56.4, 52.1, 40.2, 28.3. 
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IR ?max 3036 (w), 2943 (w), 2837 (w), 1711 (s), 1611 (w), 1445 (w), 1366 (s), 1280 (s), 1156 (s), 
1115 (s), 965 (m), 874 (m). 
HRMS (ESI) calcd for C25H30F3N2O4+ [M+H]+ 479.2152; found 479.2143. 
 
 
Tert-butyl 3-benzyl-5-(4-cyanobenzyl)-2-(trifluoromethyl)imidazolidine-1-carboxylate (32) 
 
Following General Procedure D, the title compound was prepared from 
N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 1-((tert-
butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) (85 mg, 0.33 
mmol, 1.1 equiv)  and 4-bromobenzonitrile (82 mg, 0.45 mmol, 1.5 
equiv) at 70 °C. The crude oil (>20:1 dr determined by integration of 
PhCH2N peaks in the 1H NMR) was purified by column 
chromatography on Biotage ((SNAP cartridge KP-SIL 25 g, 95:15 to 
70:30 Pentane:Et2O) affording the title compound 32 (114 mg, 0.256 
mmol, 85 % yield) as a yellow oil. 
 
 
Rf 0.30 (Pentane:Et2O 4:1).  
1H NMR (400 MHz, CDCl3????7.58 ? 7.46 (m, 2H, ArH), 7.36 ? 7.17 (m, 7H, ArH), 4.96 ? 4.82 
(m, 1H, CHCF3), 4.24 ? 4.08 (m, 1H, CHN), 3.88 (d, J = 13.1 Hz, 1H, CH2Ph), 3.73 (d, J = 13.1 
Hz, 1H, CH2Ph), 3.40 ? 3.28 (m, 1H, CH2Ar), 3.08 ? 2.97 (m, 1H, CH2N), 2.91 ? 2.81 (m, 1H, 
CH2N), 2.79 ? 2.66 (m, 1H, CH2Ar), 1.46 (s, 9H, Boc). 
13C NMR (101 MHz, CDCl3) ????????????????????2, 132.3, 130.0, 128.6 (2C), 127.8, 124.2 (q, J 
= 284.2 Hz), 118.9, 110.5, 81.6, 77.1 (m overlapping with chloroform signal), 59.6, 57.7, 56.3, 
40.3, 28.2. 
19F NMR (376 MHz, Chloroform-d????-76.2. 
IR ?max 2979 (s), 2898 (m), 1707 (m), 1376 (m), 1247 (w), 1166 (m), 1067 (s), 879 (w). 
HRMS (ESI) calcd for C24H27F3N3O2+ [M+H]+ 446.2050; found 446.2060. 
 
Methyl 3-benzyl-5-(3,5-bis(trifluoromethyl)benzyl)-2-(trifluoromethyl)imidazolidine-1-
carboxylate (33) 
 Following General Procedure D, the title compound was prepared 
from N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 2,2,2-
trifluoro-1-((methoxycarbonyl)amino)ethyl acetate (2aa) (71 mg, 0.33 
mmol, 1.1 equiv) and 1-bromo-3,5-bis(trifluoromethyl)benzene (77 µl, 
0.45 mmol, 1.5 equiv) at 70 °C. The crude oil (dr > 20 determined by 
integration in the crude 19F NMR) was purified by column 
chromatography on Biotage (SNAP cartridge KP-SIL 25 g, 85:15 to 
40:60 Pentane:CH2Cl2) affording the title compound 33 (152 mg, 
0.295 mmol, 98 % yield) as a yellow oil. 
 
Rf 0.50 (Pentane:CH2Cl2 5:7).  
1H NMR (400 MHz, CDCl3) ?????????????, ArH), 7.63 (s, 2H, ArH), 7.39 ? 7.27 (m, 5H, ArH), 
5.08 ? 4.89 (m, 1H, CHCF3), 4.29 ? 4.13 (m, 1H, CHN), 3.92 (d, J = 13.4 Hz, 1H, CH2Ph), 3.76 
(d, J = 13.5 Hz, 2H, CH2Ph), 3.73 (s, 3H, Me), 3.47 ? 3.34 (m, 1H, CH2Ar), 3.09 (dd, J = 11.6, 
6.8 Hz, 1H, CH2N), 2.98 ? 2.91 (m, 1H, CH2N), 2.88 (dd, J = 13.5, 8.7 Hz, 1H, CH2Ar). 
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13C NMR (101 MHz, CDCl3) ? 155.8, 140.3, 137.1, 131.9 (q, J = 33.2 Hz), 129.5, 128.8, 128.7, 
128.1, 124.2 (q, J = 284.4 Hz), 123.4 (q, J = 272.7 Hz), 121.04 ? 120.63 (m), 77.2 (m 
overlapping with chloroform signals), 59.6, 58.0, 56.3, 53.4, 39.6. 
19F NMR (376 MHz, CDCl3) ? -62.9, -76.5. 
IR ?max 2965 (w), 2901 (w), 1718 (m), 1451 (w), 1376 (m), 1282 (s), 1175 (s), 1137 (s), 906 (m). 
HRMS (ESI) calcd for C22H19F9N2NaO2+ [M+Na]+ 537.1195; found 537.1190. 
 
 
Tert-butyl 3-benzyl-5-(3,5-bis(trifluoromethyl)benzyl)-5-methyl-2-
(trifluoromethyl)imidazolidine-1-carboxylate (34) 
Following General Procedure C, the title compound was prepared 
from N-benzyl-2-methylprop-2-en-1-amine (45) (48.4 mg, 0.300 
mmol) and 1-((tert-butoxycarbonyl)amino)-2,2,2-trifluoroethyl 
acetate (2a) (85 mg, 0.33 mmol, 1.1 equiv), 1-bromo-3,5-
bis(trifluoromethyl)benzene (77 µl, 0.45 mmol, 1.5 equiv) at 70 
°C. The crude oil (dr > 20 determined by integration in the crude 
1H NMR) was purified by column chromatography on Biotage 
(SNAP cartridge KP-SIL 25 g, 90:10 to 60:40 Pentane:CH2Cl2) 
affording the title compound 34 (152 mg, 0.266 mmol, 89 % 
yield) as a yellow oil. 
 
Rf 0.70 (Pentane:CH2Cl2 5:7).  
1H NMR (400 MHz, CDCl3????7.75 (s, 1H, ArH), 7.63 (s, 2H, ArH), 7.37 ? 7.25 (m, 5H, ArH), 
5.04 ? 4.91 (m, 1H, CHCF3), 4.01 (d, J = 13.6 Hz, 1H, CH2Ph), 3.85 (d, J = 13.6 Hz, 1H, 
CH2Ph), 3.63 ? 3.47 (m, 1H, CH2Ar), 3.14 (d, J = 10.4 Hz, 1H, CH2N), 2.93 (d, J = 13.7 Hz, 1H, 
CH2Ar), 2.69 (dd, J = 10.3, 1.6 Hz, 1H, CH2N), 1.61 (s, 3H, Me), 1.53 (s, 9H, Boc). 
13C NMR (101 MHz, CDCl3) ? 153.1, 139.4, 137.8, 131.3 (q, J = 33.0 Hz), 130.9, 128.7, 128.4, 
127.8, 124.1 (q, J = 292.5 Hz), 123.6 (q, J = 272.5 Hz), 120.7 (m), 81.9, 76.4 (q, J = 31.3 Hz), 
64.0, 58.6, 56.5, 42.5, 28.2, 25.2. 
IR ?max 2986 (w), 2865 (w), 1704 (m), 1461 (w), 1365 (m), 1277 (s), 1166 (s), 1132 (s), 904 (m). 
HRMS (ESI) calcd for C26H28F9N2O2+ [M+H]+ 571.2002; found 571.1998. 
 
 
Tert-butyl 3-benzyl-5-((3-fluoropyridin-2-yl)methyl)-2-(trifluoromethyl)imidazolidine-1-
carboxylate (35) 
 
Following General Procedure D with DPEPhos (19 mg, 0.036 mmol) as 
ligand, the title compound was prepared from N-benzylprop-2-en-1-
amine (1) (44.2 mg, 0.300 mmol), 1-((tert-butoxycarbonyl)amino)-
2,2,2-trifluoroethyl acetate (2a) (85 mg, 0.330 mmol, 1.1 equiv) and 2-
bromo-3-fluoropyridine (79 mg, 0.45 mmol, 1.5 equiv) at 70 °C. The 
crude oil (>20:1 dr determined by integration of PhCH2N peaks in the 
1H NMR) was purified by column chromatography on Biotage (SNAP 
cartridge KP-SIL 25 g, 96:4 to 75:25 Pentane:EtOAc) affording the title 
compound 35 (88 mg, 0.20 mmol, 67 % yield) as a yellow oil. 
 
 
Rf 0.25 (Pentane:EtOAc 5:1).  
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1H NMR (400 MHz, CDCl3) ???????????J = 4.7, 1.5 Hz, 1H, HetArH), 7.26 ? 7.16 (m, 6H, ArH), 
7.08 ? 7.02 (m, 1H, HetArH), 5.01 ? 4.67 (m, 1H, CF3CH), 4.54 ? 4.23 (m, 1H, NCH), 3.79 ? 
3.67 (m, 2H, PhCH2), 3.53 ? 3.43 (m, 1H, HetArCH2), 3.18 ? 3.09 (m, 1H, NCH2), 3.09 ? 2.98 
(m, 1H, NCH2), 2.97 ? 2.87 (m, 1H, HetArCH2), 1.39 (s, 9H, Boc). 
13C NMR (101 MHz, CDCl3) ? 158.1 (d, J = 256.8 Hz), 154.5, 146.9 (d, J = 15.6 Hz), 145.0 (d, J 
= 5.4 Hz), 137.6, 128.8, 128.6, 127.8, 124.3 (q, J = 284.5 Hz), 122.9, 122.5 (d, J = 19.4 Hz), 
81.4, 77.2 (q, J = 33.2 Hz), 59.9, 57.2, 55.6, 35.7, 28.3. 
IR ?max 3068 (w), 2827 (w), 1707 (s), 1454 (m), 1366 (s), 1285 (m), 1248 (m), 1173 (s), 964 (w), 
909 (s). 
HRMS (ESI) calcd for C22H26F4N3O2+ [M+H]+ 440.1956; found 440.1951. 
 
 
Methyl 3-benzyl-5-((2-chloropyrimidin-5-yl)methyl)-2-(trifluoromethyl)imidazolidine-1-
carboxylate (36) 
 
Following General Procedure D, the title compound was prepared from N-
benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 2,2,2-trifluoro-1-
((methoxycarbonyl)amino)ethyl acetate (2aa) (71 mg, 0.33 mmol, 1.1 
equiv)  and 5-bromo-2-chloropyrimidine (87.0 mg, 0.450 mmol, 1.5 
equiv) at 70 °C. The crude oil (>20:1 dr determined by integration of 
PhCH2N peaks in the 1H NMR) was purified by column chromatography 
on Biotage (SNAP cartridge KP-SIL 25 g, 80:20 to 20:80 Pentane:Et2O) 
affording the title compound 36 (112 mg, 0.270 mmol, 90 % yield) as a 
yellow oil. 
 
 
Rf 0.25 (Pentane: Et2O 5:1).  
1H NMR (400 MHz, CDCl3) ?????????????, HetArH), 7.39 ? 7.24 (m, 5H, ArH), 5.05 ? 4.86 (m, 
1H, CF3CH), 4.16 (q, J = 7.4 Hz, 1H, NCH), 3.94 (d, J = 13.3 Hz, 1H, PhCH2), 3.75 (d, J = 13.2 
Hz, 1H, PhCH2), 3.70 (s, 3H, Me), 3.17 (dd, J = 14.1, 5.9 Hz, 1H, HetArCH2), 3.07 ? 2.94 (m, 
2H, NCH2), 2.76 (dd, J = 14.0, 7.7 Hz, 1H, HetArCH2). 
13C NMR (101 MHz, CDCl3) ? 160.0, 155.6 (2C), 136.8, 129.7, 128.8, 128.6, 128.1, 124.1 (d, J 
= 284.4 Hz), 77.2 (q, J = 33.6 Hz), 59.5, 57.6, 56.1, 53.5, 33.8.  
IR ?max 2965 (m), 2908 (w), 1713 (s), 1579 (w), 1549 (w), 1448 (m), 1393 (s), 1362 (s), 1283 
(m), 1239 (m), 1141 (s), 1072 (m), 985 (w), 912 (w), 852 (w). 
HRMS (ESI) calcd for C18H18ClF3N4NaO2+ [M+Na]+ 437.0963; found 437.0958. 
 
 
Methyl 3-benzyl-5-((5-nitrofuran-2-yl)methyl)-2-(trifluoromethyl)imidazolidine-1-
carboxylate (37) 
 
Following General Procedure D, the title compound was prepared from 
N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 2,2,2-
trifluoro-1-((methoxycarbonyl)amino)ethyl acetate (2aa) (71 mg, 0.33 
mmol, 1.1 equiv)  and 2-bromo-5-nitrofuran (86 mg, 0.45 mmol, 1.5 
equiv) at 70 °C. The crude oil (>20:1 dr determined by integration of 
PhCH2N peaks in the 1H NMR) was purified by column 
chromatography on Biotage (SNAP cartridge KP-SIL 25 g, 80:20 to 
40:60 Pentane:Et2O) affording the title compound 37 (101 mg, 0.244 
mmol, 81 % yield) as a yellow oil. 
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Rf 0.20 (Pentane: Et2O 2:1).  
1H NMR (400 MHz, CDCl3) ??7.37 ? 7.27 (m, 5H, ArH), 7.21 (d, J = 3.6 Hz, 1H, HetArH), 6.31 
(d, J = 3.6 Hz, 1H, HetArH), 5.06 ? 4.86 (m, 1H, CF3CH), 4.38 ? 4.26 (m, 1H, NCH), 3.92 (d, J 
= 13.6 Hz, 1H, PhCH2), 3.77 (d, J = 13.2 Hz, 1H, PhCH2), 3.71 (s, 3H, Me), 3.32 (d, J = 12.3 Hz, 
1H, HetArCH2), 3.21 ? 3.05 (m, 2H, NCH2), 2.88 (dd, J = 15.0, 8.1 Hz, 1H, HetArCH2). 
13C NMR (101 MHz, CDCl3) ? 156.2, 155.6, 151.9, 136.9, 128.8, 128.7, 128.0, 124.1 (q, J = 
284.3 Hz), 112.8, 111.3, 77.1 (m overlapping with chloroform signal), 59.6, 56.6, 55.5, 53.5, 
32.8. 
IR ?max 3141 (w), 2983 (w), 2962 (w), 2902 (w), 1711 (m), 1591 (w), 1529 (w), 1498 (m), 1448 
(w), 1359 (m), 1330 (w), 1285 (w), 1236 (w), 1145 (m), 1074 (w), 1025 (w), 908 (s). 
HRMS (ESI) calcd for C18H18F3N3NaO5+ [M+Na]+ 436.1091; found 436.1081. 
 
 
Methyl 5-((5-benzoylthiophen-2-yl)methyl)-3-benzyl-2-(trifluoromethyl)imidazolidine-1-
carboxylate ( 38) 
 
Following General Procedure D, the title compound was prepared from 
N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 2,2,2-trifluoro-
1-((methoxycarbonyl)amino)ethyl acetate (2aa) (71 mg, 0.33 mmol, 1.1 
equiv) and (5-bromothiophen-2-yl)(phenyl)methanone (120 mg, 0.450 
mmol, 1.5 equiv) at 70 °C. The crude oil (>20:1 dr determined by 
integration of PhCH2N peaks in the 1H NMR) was purified by column 
chromatography on Biotage (SNAP cartridge KP-SIL 25 g, 90:20 to 
50:50 Pentane:Et2O) affording the title compound 38 (120 mg, 0.246 
mmol, 82 % yield, 95 % purity) as a yellow oil. 
 
 
 
Rf 0.50 (Pentane: Et2O 1:1).  
1H NMR (400 MHz, CDCl3) ??7.85 ? 7.78 (m, 2H, ArH), 7.62 ? 7.54 (m, 1H, ArH), 7.52 ? 7.43 
(m, 3H, ArH), 7.38 ? 7.22 (m, 5H, ArH), 6.92 ? 6.80 (m, 1H, ArH), 5.16 ? 4.79 (m, 1H, CF3CH), 
4.33 ? 4.12 (m, 1H, NCH), 3.88 (d, J = 13.5 Hz, 1H, PhCH2), 3.78 (d, J = 13.5 Hz, 1H, PhCH2), 
3.78 (s, 3H, Me), 3.70 ? 3.45 (m, 1H, ArCH2), 3.21 ? 3.12 (m, 1H, NCH2), 3.07 (dd, J = 11.9, 7.4 
Hz, 1H, NCH2), 2.94 (dd, J = 14.3, 9.8 Hz, 1H, ArCH2). 
13C NMR (101 MHz, CDCl3) ? 188.0, 155.7, 149.8, 142.5, 138.1, 137.0, 135.4, 132.3, 129.2, 
128.7, 128.7, 128.5, 128.0, 127.3, 124.1 (d, J = 284.5 Hz), 77.1 (q overlapping with chloroform 
signal), 59.8, 58.0, 56.8, 53.5, 35.1. 
IR ?max 3066 (w), 2960 (w), 2903 (w), 1714 (m), 1634 (m), 1448 (s), 1365 (m), 1288 (s), 1174 
(m), 1143 (s), 909 (s). 
HRMS (ESI) calcd for C25H24F3N2O3S+ [M+H]+ 489.1454; found 489.1457. 
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Tert-butyl 3-benzyl-2-(trifluoromethyl)-5-(2-(trifluoromethyl)allyl)imidazolidine-1-
carboxylate (39) 
 
Following General Procedure D, the title compound was prepared from 
N-benzylprop-2-en-1-amine (1) (44.2 mg, 0.300 mmol), 1-((tert-
butoxycarbonyl)amino)-2,2,2-trifluoroethyl acetate (2a) (85 mg, 0.330 
mmol, 1.1 equiv) and 2-bromo-3,3,3-trifluoroprop-1-ene (79 mg, 0.45 
mmol, 1.5 eq) at 70 °C. The crude oil (>20:1 dr determined by 
integration in the crude 1H NMR) was purified by chromatography on 
Biotage (SNAP cartridge KP-SIL 25 g, 85:15 to 40:60 Pentane:CH2Cl2)  
affording the title compound 39 (115 mg, 0.262 mmol, 87 % yield) as a 
yellow oil. 
 
Rf 0.40 (Pentane:CH2Cl2 5:7).  
1H NMR (400 MHz, CDCl3) ? 7.40 ? 7.28 (m, 5H, ArH), 5.75 ? 5.65 (m, 1H, CCH2), 5.42 ? 5.30 
(m, 1H, CCH2), 5.08 ? 4.77 (m, 1H, CHCF3), 4.21 ? 4.01 (m, 1H, NCH), 3.90 (d, J = 13.4 Hz, 
1H, PhCH2), 3.77 (d, J = 13.2 Hz, 1H, PhCH2), 3.10 ? 2.94 (m, 3H, NCH2 and CH2CCF3), 2.24 
(dd, J = 14.4, 9.9 Hz, 1H, CH2CCF3), 1.48 (s, 9H, Boc). 
13C NMR (101 MHz, CDCl3) ? 154.3, 137.4, 135.1 (q, J = 30.7 Hz), 128.8 (2 signals), 128.0, 
124.4 (q, J = 284.6 Hz), 123.6 (q, J = 273.6 Hz), 120.9, 81.8, 77.0 (q overlapping with 
chloroform signals), 59.8, 56.5, 55.3, 34.8, 28.9. 
IR ?max 2979 (w), 1709 (m), 1454 (w), 1364 (m), 1288 (w), 1248 (w), 1169 (s), 1121 (s), 1072 
(w), 876 (w). 
HRMS (ESI) calcd for C20H24F6N2NaO2+ [M+Na]+ 461.1634; found 461.1648. 
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8. Products transformations. 
 
Tert-butyl 2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)imidazolidine-1-
carboxylate (14) 
 
 
 
 
 
 
 
 
 
Following a slightly modified procedure,26 a solution of tert-butyl 3-(4-methoxybenzyl)-2-
(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-yn-1-yl)imidazolidine-1-carboxylate (10) (111 
mg, 0.200 mmol) in CH2Cl2 (0.35 mL) was slowly added to a solution of DDQ (54.5 mg, 0.240 
mmol, 1.2 eq) in CH2Cl2 (1 mL) and water (0.080 mL) at 0 °C. The mixture was stirred at rt for 
10 h and then poured into ice cold water (5 mL) and extracted with CH2Cl2 (2x10 mL). The 
combined organic layers were dried over MgSO4, filtered and concentrated under reduced 
pressure. The crude residue was purified by column chromatography on Biotage (SNAP cartridge 
KP-SIL 10 g, 92:8 to 75:25 Pentane:Et2O) to give the title compound 14 (82 mg, 0.19 mmol, 94 
% yield) as a colorless oil. 
 
 
1-(4-Methoxybenzyl)-2-(trifluoromethyl)-4-(3-(triisopropylsilyl)prop-2-yn-1-
yl)imidazolidine (40) 
 
A solution of tert-butyl 3-(4-methoxybenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-
yn-1-yl)imidazolidine-1-carboxylate (10) (111 mg, 0.200 mmol) in water:ethanol (1:1, 3 mL) was 
heated under microwave irradiation at 160 °C for 15 min. The volatiles were removed under 
reduced pressure and the residue to afford the title compound 40 as a pale yellow oil (88.2 mg, 
0.194 mmol, 97 % yield, 95% purity, 1:1 dr by integration of the benzylic peaks in the 1H NMR). 
 
Rf 0.10 (EtOAc:Et3N 99:1).  
1H NMR (400 MHz, Chloroform-d) 1:1 mixture of diastereoisomers A and B ? 7.26 ? 7.19 (m, 
4H, ArH A and B), 6.89 ? 6.82 (m, 4H, ArH A and B), 4.18 ? 4.08 (m, 3H, ArCH2 B and CHCF3 
A and B), 3.99 (d, J = 13.0 Hz, 1H, ArCH2 A), 3.80 (s, 6H, OMe A and B), 3.63 (d, J = 13.0 Hz, 
1H, ArCH2 A), 3.58 (d, J = 12.7 Hz, 1H, ArCH2 B), 3.54 ? 3.45 (m, 2H, NCH A and B), 3.00 
(dd, J = 8.4, 5.2 Hz, 1H, NCH2 B), 2.94 (dd, J = 10.4, 5.6 Hz, 1H, NCH2 A), 2.83 (dd, J = 10.4, 
                                                 
26
 Lehmann, L.; Friebe M.; Brumby T.; Suelzle D.; Platzek J.  (Schering Aktiengesellschaft) WO2004/87656 A1, 
2004. 
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6.3 Hz, 1H, NCH2 A), 2.63 (dd, J = 17.3, 5.4 Hz, 2H, CH2CC B and NH), 2.52 ? 2.39 (m, 4H, 
NCH2 B CH2CC B, CH2CC A), 1.09 ? 1.04 (m, 21H, TIPS B), 1.04 ? 0.99 (m, 21H, TIPS A). 
13C NMR (101 MHz, CDCl3) 1:1 mixture of diastereoisomers ?? ????1, 159.0, 130.5, 130.3, 
130.0, 129.9, 125.5 (q, J = 282.2 Hz), 125.1 (q, J = 282.0 Hz), 113.9 (2C), 105.7, 103.1, 84.7, 
82.3, 77.7 (q overlapping with chloroform signal, J = 31.2 Hz), 77.6 (q overlapping with 
chloroform signal, J = 31.4 Hz), 58.9, 58.4, 57.5, 57.0, 55.6, 55.4 (2C), 55.3, 26.2, 22.6, 18.8, 
18.7, 11.3, 11.3. 
IR ?max 2943 (s), 2866 (m), 2173 (w), 1614 (w), 1514 (m), 1464 (m), 1382 (w), 1289 (m), 1249 
(s), 1156 (s), 1035 (m), 919 (w), 884 (m), 832 (w). 
HRMS (ESI) calcd for  C24H38F3N2OSi+ [M+H]+ 455.2700; found 455.2709. 
 
 
Tert-butyl 3-(4-methoxybenzyl)-5-(prop-2-yn-1-yl)-2-(trifluoromethyl)imidazolidine-1-
carboxylate (41) 
 
 
 
 
 
 
 
 
 
To a solution of tert-butyl 3-(4-methoxybenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-
2-yn-1-yl)imidazolidine-1-carboxylate (10) (222 mg, 0.400 mmol) in THF (Volume: 5.5 mL) at 0 
°C was added dropwise a 1N solution of TBAF (1.08 mL, 1.08 mmol, 2 equiv) in THF. The 
reaction mixture was stirred for 45 min at rt and then quenched by addition of a solution of sat. 
NH4Cl and diluted with Et2O (10 mL). The organic layer was washed with brine (2x2 mL), dried 
over MgSO4, filtered and concentrated under reduced pressure. The crude residue was purified by 
column chromatography on Biotage (SNAP cartridge KP-SIL 10 g, 93:7 to 85:15 
Pentane:EtOAc) to give the title compound 41 (156 mg, 0.392 mmol, 98 % yield) as a pale 
yellow oil. 
 
Rf 0.75 (Pentane:Et2O 2:1).  
1H NMR (400 MHz, CDCl3????7.26 ? 7.20 (m, 2H, ArH), 6.89 ? 6.84 (m, 2H, ArH), 5.06 ? 4.72 
(m, 1H, CHCF3), 4.14 ? 3.86 (m, 1H, CHNBoc), 3.79 (s, 3H, Me), 3.74 (s, 2H, ArCH2), 3.30 ? 
3.14 (m, 2H, CH2N), 3.00 ? 2.75 (m, 1H, CH2CC), 2.24 (ddd, J = 16.3, 10.1, 2.7 Hz, 1H, 
CH2CC), 1.93 (t, J = 2.7 Hz, 1H, CCH), 1.46 (s, 9H, Boc). 
13C NMR (101 MHz, CDCl3) ? 159.3, 154.1, 130.1, 129.3, 124.2 (q, J = 284.2 Hz), 114.0, 81.6, 
80.3, 77.1 (q, J = 33.3 Hz), 70.2, 59.3, 56.7, 55.5, 55.3, 28.3, 23.6. 
IR ?max 3305 (w), 3006 (w), 2937 (w), 2838 (w), 2121 (w), 1707 (s), 1613 (w), 1514 (m), 1463 
(w), 1366 (s), 1287 (m), 1249 (s), 1155 (s), 1031 (w), 872 (m). 
HRMS (ESI) calcd for C20H26F3N2O3+ [M+H]+ 399.1890; found 399.1889. 
 
 
 
 
 
 
 
S49 
 
N1-(4-methoxybenzyl)-5-(triisopropylsilyl)pent-4-yne-1,2-diamine dihydrochloride (42) 
 
 
 
A solution of tert-butyl 3-(4-methoxybenzyl)-2-(trifluoromethyl)-5-(3-(triisopropylsilyl)prop-2-
yn-1-yl)imidazolidine-1-carboxylate (10) (111 mg, 0.200 mmol) in MeOH (1 mL) at -40 °C was 
treated with a 4N HCl solution in CPME (0.125 mL, 0.500 mmol, 2.5 equiv). The reaction 
mixture was allowed to slowly warm up to rt over 5 h. Then nitrogen was bubbled in the reaction 
mixture and the volatiles were removed under reduced pressure. The residue was further dried by 
co-evaporation with toluene to afford a solid. The solid was triturated with an ice cold mixture of 
pentane and acetonitrile (4:1, 3x0.1 mL) to afford the title compound 42 (80 mg, 0.18 mmol, 89% 
yield) as a beige solid. 
 
m.p.: 185-186 °C. 
1H NMR (400 MHz, Methanol-d4?????????? 7.48 (m, 2H, ArH), 7.04 ? 6.97 (m, 2H, ArH), 4.30 
(d, J = 13.0 Hz, 1H, ArCH2), 4.24 (d, J = 13.0 Hz, 1H, ArCH2), 3.87 ? 3.78 (m, 1H, NCH), 3.82 
(s, 3H, OMe), 3.48 (dd, J = 13.8, 4.4 Hz, 1H, NCH2), 3.41 (dd, J = 13.8, 7.5 Hz, 1H, NCH2), 2.93 
(dd, J = 17.5, 5.5 Hz, 1H, CH2CC), 2.86 (dd, J = 17.5, 7.3 Hz, 1H, CH2CC), 1.16 ? 0.99 (m, 21H, 
TIPS). 
13C NMR ????? ????? ?????? ?? ??????? ????9, 123.2, 115.7, 101.0, 87.8, 55.8, 52.8, 48.9 
(overlapping with methanol signal), 48.8 (overlapping with methanol signal), 23.4, 19.0, 12.4. 
IR ?max 3408 (m), 3340 (m), 3282 (m), 2942 (w), 2864 (w), 2179 (w), 1614 (m), 1517 (s), 1463 
(m), 1307 (w), 1254 (s), 1182 (m), 1078 (s), 1037 (s), 884 (m), 836 (m). 
HRMS (ESI) calcd for C21H39N2OSi [M+H]+ 375.2826; found 375.2816. 
 
 
1-(Pyrrolidin-2-yl)-4-(triisopropylsilyl)but-3-yn-1-amine bis(2,2,2-trifluoroacetate) (43) 
 
 
 
A solution of tert-butyl 3-(trifluoromethyl)-1-(3-(triisopropylsilyl)prop-2-yn-1-yl)tetrahydro-1H-
pyrrolo[1,2-c]imidazole-2(3H)-carboxylate (20) (95.0 mg, 0.200 mmol) in DCM (2.5 mL) was 
treated with TFA (0.6 mL) at 0 °C and stirred at rt for 3 h and then dry methanol (1 mL) was 
added and the reaction was further stirred 1 h. The volatiles were removed under reduced 
pressure. The residue was further dried by co-evaporation with toluene to afford the pure title 
compound 43 (100 mg, 0.191 mmol, 96 % yield) as a light brown solid. 
 
m.p.: 121-125 °C. 
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1H NMR (400 MHz, Acetonitrile-d3) ?????????????, NH), 4.01 ? 3.89 (m, 1H, CHNH2), 3.83 ? 
3.74 (m, 1H, CHNH3), 3.36 (dd, J = 8.7, 5.9 Hz, 2H, CH2NH2), 2.89 (dd, J = 18.3, 3.9 Hz, 1H, 
CH2CC), 2.77 (dd, J = 18.3, 4.4 Hz, 1H, CH2CC), 2.35 ? 2.24 (m, 1H, CH2CHNH2), 2.18 ? 2.06 
(m, 1H, CH2CH2NH2), 2.03 ? 1.93 (m, partially overlapped with acetonitrile signal, 1H, 
CH2CH2NH2), 1.87 ? 1.73 (m, 1H, CH2CHNH2), 1.08 (s, 21H, TIPS). 
13C NMR (101 MHz, CD3??????162.8 (m), 117.5 (q, J = 292.7 Hz), 100.2, 87.7, 61.9, 51.7, 47.0, 
29.2, 24.5, 23.8, 18.9, 11.9.  
IR ?max 3518 (w), 2947 (w), 2868 (w), 2178 (w), 1672 (s), 1437 (w), 1191 (s), 1138 (s), 997 (w), 
884 (w), 841 (w). 
HRMS (ESI) calcd for C17H35N2Si [M+H]+ 295.2564; found 295.2570. 
 
 
N1-benzyl-3-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropane-1,2-diamine bis(2,2,2-
trifluoroacetate) (44) 
 
 
 
A solution of tert-butyl 3-benzyl-5-(3,5-bis(trifluoromethyl)benzyl)-5-methyl-2-
(trifluoromethyl)imidazolidine-1-carboxylate (34) (114 mg, 0.200mmol) in DCM (2.5 mL) was 
treated with TFA (0.6 mL) at 0 °C and stirred at rt for 3 h and then dry methanol (1 mL) was 
added and the reaction was further stirred 1 h. The volatiles were removed under reduced 
pressure. The residue was further dried by co-evaporation with toluene to afford the pure title 
compound 44 (122 mg, 0.197 mmol, 99% yield) as a sticky yellow oil. 
 
1H NMR (400 MHz, Acetonitrile-d3?????????????5H, NH), 7.99 (s, 1H, ArH), 7.89 ? 7.81 (m, 2H, 
ArH), 7.55 ? 7.48 (m, 2H, ArH), 7.45 ? 7.38 (m, 3H, ArH), 4.31 ? 4.19 (m, 2H, PhCH2), 3.39 (d, 
J = 14.0 Hz, 1H, NCH2), 3.37 (d, J = 14.1 Hz, 1H, ArCH2), 3.33 (d, J = 14.0 Hz, 1H, NCH2), 
3.17 (d, J = 14.1 Hz, 1H, ArCH2), 1.44 (s, 3H, Me). 
13C NMR (101 MHz, CD3??????162.5 (q, J = 35.4 Hz), 137.0, 132.5 (q, J = 33.3 Hz), 132.4 (m), 
131.3, 131.2, 130.5, 129.9, 124.4 (q, J = 272.0 Hz), 122.9 (m), 56.2, 53.5, 53.2, 42.9, 22.0. 
IR ?max 3533 (w), 3043 (w), 2838 (w), 2584 (w), 1671 (m), 1463 (w), 1437 (w), 1381 (w), 1281 
(m), 1176 (s), 1130 (s), 1030 (w), 903 (w), 840 (w). 
HRMS (ESI) calcd for C19H21F6N2 [M+H]+ 391.1603; found 391.1606. 
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9. Spectra of new compounds (1HNMR, 13CNMR, IR) 
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